<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Sjögren&#39;s Syndrome Insights</title>
    <description>Your patient and practitioner news, research and digital healthcare source</description>
    
    <link>https://sjogrens-syndrome.beehiiv.com/</link>
    <atom:link href="https://rss.beehiiv.com/feeds/vEdXkKmJIo.xml" rel="self"/>
    
    <lastBuildDate>Tue, 3 Mar 2026 00:45:27 +0000</lastBuildDate>
    <pubDate>Wed, 30 Apr 2025 18:00:00 +0000</pubDate>
    <atom:published>2025-04-30T18:00:00Z</atom:published>
    <atom:updated>2026-03-03T00:45:27Z</atom:updated>
    
    <copyright>Copyright 2026, Sjögren&#39;s Syndrome Insights</copyright>
    
    <image>
      <url>https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/publication/logo/6067e0be-a2bd-4309-867e-a0cab7759354/Icon_Blue.png</url>
      <title>Sjögren&#39;s Syndrome Insights</title>
      <link>https://sjogrens-syndrome.beehiiv.com/</link>
    </image>
    
    <docs>https://www.rssboard.org/rss-specification</docs>
    <generator>beehiiv</generator>
    <language>en-us</language>
    <webMaster>support@beehiiv.com (Beehiiv Support)</webMaster>

      <item>
  <title>Sjögren&#39;s Syndrome Insights</title>
  <description>Cullinan Therapeutics Initiates CLN-978 Trial for Sjögren&#39;s Syndrome</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/30042025</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/30042025</guid>
  <pubDate>Wed, 30 Apr 2025 18:00:00 +0000</pubDate>
  <atom:published>2025-04-30T18:00:00Z</atom:published>
    <category><![CDATA[Newsletter]]></category>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><div class="custom_html"><table role="presentation" style="width: 100%; max-width: 600px; margin: 0 auto; background-color: #f6f4f2; overflow: hidden; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Top Stories</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><a href="https://www.globenewswire.com/news-release/2025/04/29/3070028/0/en/Cullinan-Therapeutics-to-Initiate-Study-of-CLN-978-a-Bispecific-CD19-T-Cell-Engager-Administered-Subcutaneously-in-Patients-with-Sj%C3%B6gren-s-Disease-in-the-United-States.html?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=news&utm_topic=pharmaceutical-insights" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgb(235,232,230); border-left: 4px solid rgb(6,125,143); transition: background 0.2s ease;"><div style="color: rgb(48,44,42); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Cullinan Therapeutics Initiates CLN-978 Trial for Sjögren's Syndrome</div><div style="margin: 0; line-height: 1.6; color: #444; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">Researchers are testing CLN-978, a new therapy, to see if it can safely help people with Sjögren's Syndrome, a condition with no current treatments. This study aims to evaluate its safety and effects on the condition.</div><span style="color: rgb(6,125,143); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a><a href="https://www.ophthalmologytimes.com/view/characteristics-of-dry-eye-disease-in-patients-with-autoimmune-diseases?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=news&utm_topic=diagnostic-insights" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgb(235,232,230); border-left: 4px solid rgb(6,125,143); transition: background 0.2s ease;"><div style="color: rgb(48,44,42); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Autoimmune Link to Dry Eye Characteristics</div><div style="margin: 0; line-height: 1.6; color: #444; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">People with Sjögren's Syndrome often experience dry eye due to their immune system affecting tear glands. This condition can lead to chronic inflammation and discomfort on the eye's surface.</div><span style="color: rgb(6,125,143); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; text-align: justify">Latest Research</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><div style="margin: 0; padding: 20px; border-radius: 8px;"><div style="color: rgb(48,44,42); text-align: justify; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"><p style="margin: 0 0 15px 0; line-height: 1.6;">Recent research into autoimmune diseases like Sjögren's Syndrome has focused on developing targeted therapies. These treatments aim to reduce harmful immune cells by targeting specific proteins involved in the immune response. For instance, researchers have developed an afucosylated anti-CXCR5 antibody designed to block certain interactions and promote the removal of harmful cells through antibody-dependent cellular cytotoxicity (ADCC).<br/><br/> This approach could lead to more precise treatments with fewer side effects, offering new hope for patients. By focusing on specific immune system components, researchers aim to reduce inflammation and other symptoms associated with autoimmune conditions. This development suggests a growing interest in managing these diseases more effectively, as seen in the work of <a href="https://rupress.org/jhi/article/1/CIS2025/CIS2025abstract.30/277572?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="color: rgb(6,125,143) !important; text-decoration: none;" target="_blank"><span style="color: rgb(6,125,143);"><strong>Ducos et al. (2025)</strong></span></a>.</p></div></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Clinical Trials</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><div style="margin: 0 20px 25px; text-align: justify; color: rgb(48,44,42); font-size: 16px; line-height: 1.6;"> This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks: </div><div style="margin: 0 20px;"><a href="https://clinicaltrials.gov/study/NCT06440525?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=phase-ii" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Study of RSLV-132 in Females With Sjögren's Syndrome </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,0.75); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase II</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">United States</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18 - 65 Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">106</div></td></tr></table></div></a><a href="https://clinicaltrials.gov/study/NCT06312020?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=phase-ii" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,0.75); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase II</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">18 countries</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18 - 75 Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">262</div></td></tr></table></div></a><div style="text-align: left; margin-top: 30px; margin-bottom: 20px;"><a href="https://clinicaltrials.gov/search?cond=Sj%C3%B6gren%27s%20Syndrome&aggFilters=status:rec&utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=all-trials" rel="noopener noreferrer" style="color: rgb(6,125,143); text-decoration: none; font-weight: bold; font-size: 15px;" target="_blank"> View the full list of clinical trials → </a></div></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Community News</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><a href="https://www.facebook.com/1024838096347853/posts/1088652249966437?utm_source=sjögren's-syndrome-insights&utm_content=community" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Apr 28, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">Sjögren's is a serious, systemic, and complex disease that is still under recognized. 79% of Sjögren's patient say living with Sjögren’s makes every day a challenge. Despite that, 69%<br/><br/>say they are still able to live a fullfilling life despite their disease.<br/><br/><strong style="color: rgb(6,125,143);">#ThisIsSjögrens</strong></p></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><a href="https://www.facebook.com/1024838096347853/posts/1085865760245086?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=personal-stories" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Apr 25, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">Debra<br/><br/>'I will say this, through counseling, I learned that I am morning my former life and trying to navigate my new life with Sjögren’s.<br/><br/>Thankfully my spouse is an Optometrist. I didn’t even know what Sjögren’s was. When I was diagnosed it was the first time I heard of it. My husband knew all about it. He is very supportive and has treated Sjögren eye related issues for years. He also knows the struggles patients endure trying to get the right diagnosis. He has actually related to me that on a particular day that he had a patient that sounded exactly like me, trying to navigate all of the symptoms and just find the right combination of therapies to get relief and try to lead as best of a normal life as possible.<br/><br/>Take a breath … this disease is chronic. It is manageable. Listen to your body, you now have limitations. Over doing or over stressing will lead to symptom onset. Educate those that are closest to you. Print the human body diagram that the Sjögren’s Foundation has on their site. Give it to everyone that you think needs education about the disease. It is a systemic disease, that seems to have a mind of its own. You never know when it will affect a body's systems. Seek a good Rheumatologist, one versed in Sjögren’s. Understand your PCP is most likely limited in their knowledge of the disease. You may be tasked with educating them as well. I learned, in case this disease has debilitated you, that it is recognized by Social Security as a disability. Lastly, you are not in this alone, seek support, whether it be counseling, support groups, education is also key. You are not a hypochondriac your symptoms are real!'<br/><br/>To learn more of Debra's story click the link below:<br/><br/><strong style="color: rgb(6,125,143);">https://sjogrens.org/awareness-stories</strong><br/><br/><strong style="color: rgb(6,125,143);">#ThisIsSjögrens</strong></p></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><a href="https://www.facebook.com/1038746394958913/posts/1100888665411352?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=patient-resources" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Beyond Sjögren's" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/108469241318499.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Beyond Sjögren's</strong><span style="color: #999; font-size: 14px; display: block;">Apr 24, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">What is really possible when it comes to improving health and symptoms with Sjögren's?<br/><br/>Over the past few years, we’ve had the privilege of supporting dozens of people with Sjögren’s - and we’ve seen firsthand that while there’s no quick fix, progress is absolutely possible.<br/><br/>In this post, we’re sharing 5 key lessons that we have learned from those who have seen meaningful improvements to their health and symptoms, so you can take these insights and apply them to your own journey too.<br/><br/>⬆️ Tap through to learn what has helped others feel better with Sjögren’s, and how it might help you too.<br/><br/>---<br/><br/>💡 Want to learn more?<br/><br/>We have launched a course to help people with Sjögren’s improve their health, through Sjögren’s-specific diet, supplement, movement, stress and sleep recommendations and much more.<br/><br/>Follow the link in bio or comment 'COURSE' for more.<br/><br/>Use code "awareness10" at checkout for 10% off the course price. Available until the end of April.<br/><br/>---</p></div></a><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">Upcoming Events</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div></td></tr><tr><td><table style="width: 100%; max-width: 600px; margin-bottom: 28px; padding-top: 20px; border: none; border-collapse: separate; overflow: hidden;"></table></td></tr></div></td></tr></table><tr><td style="padding: 15px 0;"></td></tr><tr><td style="padding: 0 0 20px 0;"><div style="text-align: center;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle; margin-right: -5px;"></div><a href="https://www.allmyhealth.io/our-communities/sjögren's-syndrome" rel="noopener noreferrer" style="display: inline-block; padding: 8px 16px; background-color: white; color: rgb(6,125,143); text-decoration: none; border-radius: 10px; font-family: Roboto, Arial, sans-serif; font-size: 14px; border: 1px solid rgb(6,125,143); margin: 0; font-weight: bold;" target="_blank"> Subscribe </a><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle; margin-left: -5px;"></div></div></td></tr></div></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=76552fdf-2683-48b5-b1c2-cba8223a2a41&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Sjögren&#39;s Syndrome Insights</title>
  <description>Men with Sjögren&#39;s at higher pulmonary hypertension risk</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/23042025</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/23042025</guid>
  <pubDate>Wed, 23 Apr 2025 18:00:00 +0000</pubDate>
  <atom:published>2025-04-23T18:00:00Z</atom:published>
    <category><![CDATA[Newsletter]]></category>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><div class="custom_html"><table role="presentation" style="width: 100%; max-width: 600px; margin: 0 auto; background-color: #f6f4f2; overflow: hidden; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Top Stories</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><a href="https://sjogrenssyndromenews.com/news/men-sjogrens-be-higher-risk-pulmonary-hypertension/?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=news&utm_topic=diagnostic-insights" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgb(235,232,230); border-left: 4px solid rgb(6,125,143); transition: background 0.2s ease;"><div style="color: rgb(48,44,42); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Men with Sjögren's at higher pulmonary hypertension risk</div><div style="margin: 0; line-height: 1.6; color: #444; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">Men with Sjögren's Syndrome may develop more severe lung and heart issues, increasing their risk of pulmonary hypertension. Regular heart monitoring is recommended for these patients.</div><span style="color: rgb(6,125,143); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a><a href="https://www.healio.com/news/rheumatology/20250416/weve-come-a-long-way-recent-sjgrens-research-provides-more-hope-than-ever-before?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=news" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgb(235,232,230); border-left: 4px solid rgb(6,125,143); transition: background 0.2s ease;"><div style="color: rgb(48,44,42); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Recent Advances Bring New Treatment Options for Sjögren's Syndrome</div><div style="margin: 0; line-height: 1.6; color: #444; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"></div><span style="color: rgb(6,125,143); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; text-align: justify">Latest Research</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><div style="margin: 0; padding: 20px; border-radius: 8px;"><div style="color: rgb(48,44,42); text-align: justify; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"><p style="margin: 0 0 15px 0; line-height: 1.6;">A recent case report describes the treatment of primary Sjögren's syndrome complicated by immune thrombocytopenia using tofacitinib.<br/><br/>Sjögren's syndrome is an autoimmune disorder mainly affecting the salivary and lacrimal glands, which produce saliva and tears.<br/><br/>The addition of immune thrombocytopenia, characterized by low platelet counts due to immune dysfunction, complicates disease management.<br/><br/>Tofacitinib, an immune-modulating medication, was used to address the autoimmune components of both conditions.<br/><br/>This treatment approach reflects ongoing efforts to find effective therapies for complex autoimmune diseases like Sjögren's syndrome, which can have systemic complications including lymphoma and neurological issues <a href="https://onlinelibrary.wiley.com/doi/abs/10.1111/1756-185X.70225?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="color: rgb(6,125,143) !important; text-decoration: none;" target="_blank"><span style="color: rgb(6,125,143);"><strong>(Ning et al., 2025)</strong></span></a>.</p></div></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Clinical Trials</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><div style="margin: 0 20px 25px; text-align: justify; color: rgb(48,44,42); font-size: 16px; line-height: 1.6;"> This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks: </div><div style="margin: 0 20px;"><a href="https://clinicaltrials.gov/study/NCT06312020?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=phase-ii" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,0.75); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase II</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">18 countries</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18 - 75 Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">262</div></td></tr></table></div></a><a href="https://clinicaltrials.gov/study/NCT06747949?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=phase-iii" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,1); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase III</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">United States</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18+ Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">844</div></td></tr></table></div></a><div style="text-align: left; margin-top: 30px; margin-bottom: 20px;"><a href="https://clinicaltrials.gov/search?cond=Sj%C3%B6gren%27s%20Syndrome&aggFilters=status:rec&utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=all-trials" rel="noopener noreferrer" style="color: rgb(6,125,143); text-decoration: none; font-weight: bold; font-size: 15px;" target="_blank"> View the full list of clinical trials → </a></div></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Community News</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><a href="https://www.facebook.com/1024838096347853/posts/1079938624171133?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=personal-stories" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Apr 17, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">Barbara<br/><br/>'I was diagnosed with Sjögren’s in my mid forties soon after I began to experience dry eyes and mouth as well as fatigue. At age fifty I experienced forced retirement from my position as a registered nurse because I had used up all of my paid time off after surgery for back to back rotator cuff repairs. Other physical issues related to Sjögren’s over the years had also eaten into my accumulated sick leave benefits. My position in a large medical school as an RN in the Dept. of pediatrics for 32+ years came to an abrupt and sudden end mandated by HR. No problem they said. You can draw short term disability then file for SSDI. You’ll be fine. Have your office cleaned out by 5:00 today! I was not able to fight back the tears. Emotionally I was devastated after a long career filled with knowledge that still needed to be shared for the well-being and care of babies born prematurely and their parents who needed training on how to care for them. At age 50, I had a lot left to give but Sjögren’s and the prevailing culture that anyone with a disability is a company liability and waste of resources, cut that short. I didn’t know what to do with my time and I had to begin to redefine myself. It took a major toll on my self esteem and I felt somewhat worthless and depressed. To this day, I just turned 72, I still have unresolved feelings of disappointment and resentment to deal with.<br/><br/>I wish my loved ones and friends could truly understand what I go through every single day of my life. I never feel fully rested and it’s frustrating to have to acknowledge my limitations and to miss out on activities because I’m just too darn tired. I wish they truly understood that my whole body is affected by this disease and that I often hide how I feel because frankly I loathe being a complainer. I hate relying on others for help when I was always the one everyone depended on at home and at work when someone else was in need.'<br/><br/>Click the link below to read more of Barbara's story:<br/><br/><strong style="color: rgb(6,125,143);">https://sjogrens.org/awareness-stories</strong><br/><br/><strong style="color: rgb(6,125,143);">#ThisIsSjögrens</strong></p></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><a href="https://www.facebook.com/1024838096347853/posts/1083140567184272?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=patient-survey" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Apr 21, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">A number of different medications are available that can be used to manage symptoms. Currently, no single medication has been conclusively proven to slow the progression of Sjögren’s or treat all aspects of the disease.<br/><br/>On average, respondents to our 2021 Living With Sjögren's Patient Survey use 3.7 OTC products, 3.3 prescription products and see 4.4 health care providers, annually.<br/><br/>However, 23% of respondents reported using 10+ medications and seeing 6+ health care providers.<br/><br/><strong style="color: rgb(6,125,143);">#ThisIsSjögrens</strong></p></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><a href="https://www.facebook.com/1038746394958913/posts/1099269262239959?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=patient-resources" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Beyond Sjögren's" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/108469241318499.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Beyond Sjögren's</strong><span style="color: #999; font-size: 14px; display: block;">Apr 22, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">Have you noticed the air quality in your home affecting your Sjögren's symptoms?<br/><br/>Our homes can be a significant source of indoor air pollution, and contribute to increasing inflammation.<br/><br/>The good news is you can easily address this. Swipe to learn how!<br/><br/>---<br/><br/>Want to learn more?<br/><br/>Our new course teaches you how to reduce your toxic load with Sjögren’s, so you can reduce your inflammation and improve your health.<br/><br/>We have 48 hours left for 10% off the course price - use code "awareness10" at checkout.<br/><br/>Follow the link in bio or comment 'COURSE' for more.<br/><br/>---</p></div></a><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">Upcoming Events</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div></td></tr><tr><td><table style="width: 100%; max-width: 600px; margin-bottom: 28px; padding-top: 20px; border: none; border-collapse: separate; overflow: hidden;"></table></td></tr></div></td></tr></table><tr><td style="padding: 15px 0;"></td></tr><tr><td style="padding: 0 0 20px 0;"><div style="text-align: center;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle; margin-right: -5px;"></div><a href="https://www.allmyhealth.io/our-communities/sjögren's-syndrome" rel="noopener noreferrer" style="display: inline-block; padding: 8px 16px; background-color: white; color: rgb(6,125,143); text-decoration: none; border-radius: 10px; font-family: Roboto, Arial, sans-serif; font-size: 14px; border: 1px solid rgb(6,125,143); margin: 0; font-weight: bold;" target="_blank"> Subscribe </a><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle; margin-left: -5px;"></div></div></td></tr></div></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=f9e3efcf-3d69-4565-84b4-c975f4e7a0ff&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Sjögren&#39;s Syndrome Insights</title>
  <description>Scientists Discover Key to Treating Dry Mouth Disorder</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/16042025</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/16042025</guid>
  <pubDate>Wed, 16 Apr 2025 18:00:00 +0000</pubDate>
  <atom:published>2025-04-16T18:00:00Z</atom:published>
    <category><![CDATA[Newsletter]]></category>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><div class="custom_html"><table role="presentation" style="width: 100%; max-width: 600px; margin: 0 auto; background-color: #f6f4f2; overflow: hidden; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Top Stories</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><a href="https://scitechdaily.com/affecting-millions-scientists-discover-key-to-treating-painful-dry-mouth-disorder/?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=news&utm_topic=clinical-breakthroughs" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgb(235,232,230); border-left: 4px solid rgb(6,125,143); transition: background 0.2s ease;"><div style="color: rgb(48,44,42); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Scientists Discover Key to Treating Dry Mouth Disorder</div><div style="margin: 0; line-height: 1.6; color: #444; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">New treatments for dry mouth, like an investigational drug and microRNA blockade, could benefit those with Sjögren's Syndrome, who often experience persistent dry mouth due to reduced saliva production.</div><span style="color: rgb(6,125,143); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; text-align: justify">Latest Research</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><div style="margin: 0; padding: 20px; border-radius: 8px;"><div style="color: rgb(48,44,42); text-align: justify; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"><p style="margin: 0 0 15px 0; line-height: 1.6;">Recent research into Primary Sjögren's Syndrome (pSS) has focused on its genetic aspects. This chronic autoimmune disease is being studied to better understand its development and progression. By identifying key genes involved in the disease's pathogenesis, researchers can gain insights into potential therapeutic targets or diagnostic markers.<br/><br/> These findings are significant because they highlight specific genetic factors contributing to the disease. This work is crucial for advancing our understanding of pSS and could lead to more effective treatments or management strategies in the future. The study's approach could help uncover more about how these genes influence the disease's progression and how they can be targeted to improve patient outcomes <a href="https://link.springer.com/article/10.1007/s10067-025-07428-6?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="color: rgb(6,125,143) !important; text-decoration: none;" target="_blank"><span style="color: rgb(6,125,143);"><strong>(Wang et al., 2025)</strong></span></a>.</p></div></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Clinical Trials</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><div style="margin: 0 20px 25px; text-align: justify; color: rgb(48,44,42); font-size: 16px; line-height: 1.6;"> This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks: </div><div style="margin: 0 20px;"><a href="https://clinicaltrials.gov/study/NCT06312020?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=phase-ii" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,0.75); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase II</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">17 countries</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18 - 75 Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">262</div></td></tr></table></div></a><a href="https://clinicaltrials.gov/study/NCT06780293?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=phase-ii" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS) </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,0.75); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase II</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">Taiwan</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">20 - 75 Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">140</div></td></tr></table></div></a><a href="https://clinicaltrials.gov/study/NCT06747949?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=phase-iii" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,1); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase III</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">United States</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18+ Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">844</div></td></tr></table></div></a><a href="https://clinicaltrials.gov/study/NCT05946941?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=phase-iii" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,1); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase III</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">34 countries</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18+ Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">756</div></td></tr></table></div></a><div style="text-align: left; margin-top: 30px; margin-bottom: 20px;"><a href="https://clinicaltrials.gov/search?cond=Sj%C3%B6gren%27s%20Syndrome&aggFilters=status:rec&utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=all-trials" rel="noopener noreferrer" style="color: rgb(6,125,143); text-decoration: none; font-weight: bold; font-size: 15px;" target="_blank"> View the full list of clinical trials → </a></div></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Community News</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><a href="https://www.facebook.com/1024838096347853/posts/1074475351384127?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=patient-resources" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Apr 10, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">Brain Fog is a lay term to describe fluctuating mild memory loss that is inappropriate for a person’s age. It may include forgetfulness, spaciness, confusion, decreased ability to pay attention, an inability to focus, and difficulty in processing information. Remember that gradual cognitive decline from early adulthood is a fact of life. Brain Fog can occur in Sjögren’s, but other factors might cause these symptoms and should be considered by you and your doctor.<br/><br/>According to the Livivng With Sjögren's Patient Survey, 80% of Sjögren's patients experience Brain Fog.<br/><br/>For more information on Brain Fog and other symptoms, click the link below:<br/><br/><strong style="color: rgb(6,125,143);">https://sjogrens.org/understanding-sjogrens/resources/brochures-resource-sheets</strong></p></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><a href="https://www.facebook.com/1024838096347853/posts/1077618807736448?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=personal-stories" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Apr 14, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">An estimated 70% of Sjögren's patients have at least one other immune related health condition in addition to their Sjögren's. An estimated 49% of patients have two or more conditions. These conditions can include but are not limited to:<br/><br/>- Fibromyalgia<br/><br/>- Rheumatoid Arthritis<br/><br/>- Hashimoto’s Hypothyroidism<br/><br/>- Mixed Connective Tissue Disease<br/><br/>- Systemic Lupus Erythematosus (SLE)<br/><br/>- Celiac Disease (gluten enteropathy)<br/><br/>- Graves’ Disease<br/><br/>- Scleroderma<br/><br/><strong style="color: rgb(6,125,143);">#ThisIsSjögrens</strong></p></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><a href="https://www.facebook.com/1038746394958913/posts/1093740262792859?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=patient-resources" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Beyond Sjögren's" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/108469241318499.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Beyond Sjögren's</strong><span style="color: #999; font-size: 14px; display: block;">Apr 15, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">Does your skin get dry and irritated after using certain skin-care products?<br/><br/>It's no surprise! So many of the cosmetics we use are full of irritating, and sometimes even toxic, ingredients (yes, even the expensive ones!).<br/><br/>Let's break it down.<br/><br/>🚫 The worst offenders for dry and sensitive skin are:<br/><br/>- Alcohols (including ethanol, denatured alcohol, isopropyl alcohol): they strip moisture from skin and cause irritation. Cetyl and stearyl alcohol are usually ok.<br/><br/>- Fragrance / parfum: even if they are labelled as 'natural', they are common triggers for skin irritation, and are also endocrine (hormone) disruptors.<br/><br/>- Sulfates (sodium lauryl/laureth sulfate, or SLS): strip natural oils from the skin and make dryness worse.<br/><br/>- Parabens: also endocrine disruptors, and can make inflammation worse.<br/><br/>- Essential oils in high doses: can cause irritation in sensitive skins.<br/><br/>- Petrolatum and mineral oils: although they moisturise skin in the short term, they can block pores and prevent the skin from breathing (which isn't great for inflamed skin).<br/><br/>- Retinoids (retinol, tretinoin): also very drying and irritating.<br/><br/>- Waterproof mascaras, harsh removers, eyeliners with glitter or strong pigments: can migrate into the eye and cause irritation.<br/><br/>✅ Better alternatives:<br/><br/>- Fragrance and alcohol-free products.<br/><br/>- Gentle cream or oil-based cleansers.<br/><br/>- Moisturizers with ceramides, hyaluronic acid, squalane and/or shea butter.<br/><br/>- Products labelles as eye-safe and ophtalmologist-tested.<br/><br/>- Non-toxic lip balms without strong menthol or camphor (can dry out lips).<br/><br/>- Bakuchiol as a natural, gentler alternative to retinols.<br/><br/>💡 Want to learn more?<br/><br/>Our "Healing with Sjögren's Naturally" course contains a whole in-depth lesson on environmental toxins, their effect on Sjögren's, and how to easily avoid them, including useful apps and resources that will make your life easier.<br/><br/>Comment "COURSE" and we will send you more info!</p></div></a><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">Upcoming Events</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div></td></tr><tr><td><table style="width: 100%; max-width: 600px; margin-bottom: 28px; padding-top: 20px; border: none; border-collapse: separate; overflow: hidden;"></table></td></tr></div></td></tr></table><tr><td style="padding: 15px 0;"></td></tr><tr><td style="padding: 0 0 20px 0;"><div style="text-align: center;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle; margin-right: -5px;"></div><a href="https://www.allmyhealth.io/our-communities/sjögren's-syndrome" rel="noopener noreferrer" style="display: inline-block; padding: 8px 16px; background-color: white; color: rgb(6,125,143); text-decoration: none; border-radius: 10px; font-family: Roboto, Arial, sans-serif; font-size: 14px; border: 1px solid rgb(6,125,143); margin: 0; font-weight: bold;" target="_blank"> Subscribe </a><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle; margin-left: -5px;"></div></div></td></tr></div></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=7deb847a-994f-4825-a7f4-ce016037b932&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Sjögren&#39;s Syndrome Insights</title>
  <description>Autoimmune Hepatitis and Sjögren&#39;s Syndrome Overlap Case</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/09042025</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/09042025</guid>
  <pubDate>Wed, 09 Apr 2025 18:00:00 +0000</pubDate>
  <atom:published>2025-04-09T18:00:00Z</atom:published>
    <category><![CDATA[Newsletter]]></category>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><div class="custom_html"><table role="presentation" style="width: 100%; max-width: 600px; margin: 0 auto; background-color: #f6f4f2; overflow: hidden; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Top Stories</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><a href="https://www.cureus.com/articles/349848-autoimmune-hepatitis-primary-biliary-cholangitis-overlap-in-a-case-of-pulmonary-arterial-hypertension-and-sjgrens-syndrome-occams-razor-or-hickams-dictum?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=news&utm_topic=personal-stories" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgb(235,232,230); border-left: 4px solid rgb(6,125,143); transition: background 0.2s ease;"><div style="color: rgb(48,44,42); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Autoimmune Hepatitis and Sjögren's Syndrome Overlap Case</div><div style="margin: 0; line-height: 1.6; color: #444; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">Involving Sjögren's Syndrome, a condition causing dry eyes and mouth, this case highlights complex liver issues when combined with autoimmune hepatitis and primary biliary cholangitis. The combination affects treatment and liver health.</div><span style="color: rgb(6,125,143); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a><a href="https://www.cureus.com/articles/352302-recurrent-pneumothoraces-in-a-patient-with-anti-sjgrens-syndrome-a-antibody-positive-cystic-lung-disease-an-atypical-presentation-of-sjgrens-disease?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=news&utm_topic=diagnostic-insights" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgb(235,232,230); border-left: 4px solid rgb(6,125,143); transition: background 0.2s ease;"><div style="color: rgb(48,44,42); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Recurrent Pneumothoraces in Sjögren's Syndrome Patient</div><div style="margin: 0; line-height: 1.6; color: #444; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">A 54-year-old man with Sjögren's Syndrome experienced recurring lung collapses due to cystic lung disease, highlighting unusual lung complications associated with this condition.</div><span style="color: rgb(6,125,143); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; text-align: justify">Latest Research</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><div style="margin-bottom: 0px 20px 20px 20px; padding: 20px;"><div style="margin: 0; line-height: 1.6; color: #444; text-align: justify; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">Recent research highlights significant immune changes in patients with primary Sjögren’s disease (pSjD). A study compared immune cell types and interferon expression in placentas from patients with systemic lupus erythematosus and pSjD, revealing higher levels of Myxovirus resistance protein 1 and an increased count of macrophages in the placentas of those with pSjD. These findings suggest that immune dysregulation may play a crucial role in the pathophysiology of Sjögren’s syndrome, indicating potential avenues for targeted therapies and a deeper understanding of the disease's impact on systemic health. <br/><br/> The study emphasizes the importance of recognizing immune alterations in Sjögren’s syndrome, which can lead to various systemic complications. This research contributes to the growing body of evidence that links autoimmune conditions with significant immune system changes, potentially paving the way for improved diagnostic and therapeutic strategies in managing Sjögren’s syndrome and related disorders. <a href="https://link.springer.com/article/10.1007/s00296-025-05856-w?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="color: rgb(6,125,143) !important; text-decoration: none;" target="_blank"><span style="color: rgb(6,125,143);"><strong>(Fierro, 2025)</strong></span></a></div></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Clinical Trials</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><div style="margin: 0 20px 25px; text-align: justify; color: rgb(48,44,42); font-size: 16px; line-height: 1.6;"> This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks: </div><div style="margin: 0 20px;"><a href="https://clinicaltrials.gov/study/NCT06312020?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=phase-ii" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,0.75); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase II</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">17 countries</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18 - 75 Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">262</div></td></tr></table></div></a><a href="https://clinicaltrials.gov/study/NCT05946941?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=phase-iii" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,1); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase III</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">34 countries</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18+ Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">756</div></td></tr></table></div></a><a href="https://clinicaltrials.gov/study/NCT06245408?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=phase-iii" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,1); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase III</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">27 countries</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18+ Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">435</div></td></tr></table></div></a><a href="https://clinicaltrials.gov/study/NCT06104124?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=phase-iii" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,1); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase III</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">28 countries</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18+ Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">621</div></td></tr></table></div></a><div style="text-align: left; margin-top: 30px; margin-bottom: 20px;"><a href="https://clinicaltrials.gov/search?cond=Sj%C3%B6gren%27s%20Syndrome&aggFilters=status:rec&utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=all-trials" rel="noopener noreferrer" style="color: rgb(6,125,143); text-decoration: none; font-weight: bold; font-size: 15px;" target="_blank"> View the full list of clinical trials → </a></div></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Community News</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><a href="https://www.facebook.com/1024838096347853/posts/1066713862160276?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=patient-resources" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Apr 01, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">Sjögren’s disease is one of the most prevalent yet underrecognized autoimmune diseases, affecting millions of people worldwide. Despite its impact, awareness remains low, and many patients experience delays in diagnosis and a lack of treatment options.<br/><br/>This month, we invite you to Connect, Learn and Thrive. Connect with the Sjögren’s community,<br/><br/>Learn more about the disease and ways to bring awareness to its impact, and Thrive by accessing resources and support that empower you to live your best life with Sjögren’s.<br/><br/>Click the link below to learn more about Sjögren's Awareness Month:<br/><br/><strong style="color: rgb(6,125,143);">https://www.sjogrens.org/sjogrensmonth</strong><br/><br/><strong style="color: rgb(6,125,143);">#ThisIsSjögrens</strong></p><div style="width: 100%; margin: 20px 0; border-radius: 5px;"><img alt="Sjögren's Foundation Post" src="https://healthspotlight-newsletters.s3.amazonaws.com/post_images/6067e0be-a2bd-4309-867e-a0cab7759354-20250408-1" style="width: 100%; height: auto; display: block;"/></div></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><a href="https://www.facebook.com/1024838096347853/posts/1068798921951770?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=news-and-updates" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Apr 03, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">Sjögren's is a complex disease and can be difficult to diagnose, and it's not uncommon to face challenges along the way. If you feel like something isn't right, continue to advocate for yourself and be persistent in your search for answers.<br/><br/>Currently, the two most prevalently used tests to clearly diagnose Sjögren’s are testing positive on a lip biopsy and testing positive for a prominent autoantibody associated with Sjögren’s known as anti-SSA (also called anti-Ro). However, an estimated 40% of Sjögren's patients are considered 'Seronegative', meaning they are not positive for anti-SSA, despite having clear indications of having Sjögren's disease.</p></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><a href="https://www.facebook.com/1038746394958913/posts/1081795870653965?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=fundraising-and-events" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Beyond Sjögren's" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/108469241318499.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Beyond Sjögren's</strong><span style="color: #999; font-size: 14px; display: block;">Apr 01, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">April is Sjögren's Awareness Month, and we want to take this opportunity to bring awareness to the challenges that people with Sjögren's suffer with:<br/><br/>👉 What is Sjögren's?<br/><br/>Sjögren's is a relatively common autoimmune disease that is most commonly known for damaging moisture producing glands - like tear and saliva glands - causing severe dry eyes and/or mouth.<br/><br/>However, the disease often impacts far more these glands, and can affect the whole body, causing deilitating fatigue, digestive issues, joint and nerve pain, brain fog and more.<br/><br/>👉 How does it affect those who suffer with it?<br/><br/>- They often live with a deep exhaustion that doesn’t improve with rest and can make even the simplest tasks feel overwhelming.<br/><br/>- Joint pain, nerve pain, and muscle aches are common and may come and go unpredictably.<br/><br/>- Many also experience brain fog, which makes it difficult to concentrate, find the right words, or think clearly.<br/><br/>- The disease can also affect the gut, pancreas, liver, and nutrient absorption, leading to digestive and nutritional challenges.<br/><br/>- Since it’s an invisible illness, this can bring emotional strain, including feelings of isolation, misunderstanding, and the pressure to keep going despite everything.<br/><br/>- Flare-ups often strike without warning, making it difficult to plan ahead or keep up with daily life.<br/><br/>- Most people spend years searching for answers before finally receiving a diagnosis.<br/><br/>- Many also experience dismissal or a lack of support from health professionals, often due to how nonspecific or misunderstood the symptoms can be.<br/><br/>Despite how life-altering it can be, and how relatively common it is, Sjögren’s receives far less funding and public attention compared to other autoimmune conditions.<br/><br/>People with Sjögren’s deserve to be seen, heard and supported. Let’s hope we can move closer to that goal this April.<br/><br/>Share this post to raise awareness!<br/><br/>--</p></div></a><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">Upcoming Events</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div></td></tr><tr><td><table style="width: 100%; max-width: 600px; margin-bottom: 28px; padding-top: 20px; border: none; border-collapse: separate; overflow: hidden;"><tr><td rowspan="1" style="width: 110px; text-align: center; vertical-align: top; padding: 0; border: none; padding-bottom: 40px;"><table style="width: 110px; border: 3px solid rgb(6,125,143); border-radius: 18px; background: #f6f4f2; border-collapse: separate; overflow: hidden;"><tr><td style="background: rgb(6,125,143); color: white; text-align: center; padding: 8px 0; font-weight: bold; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important; border-radius: 15px 15px 0 0; font-size: 16px;"> APR </td></tr><tr><td style="text-align: center; padding: 8px 0; font-size: 36px; font-weight: bold; color: rgb(6,125,143); font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"> 11 </td></tr></table></td><td style="padding: 0 0 40px 20px; border: none; vertical-align: top;"><div style="margin: 0;"><span style="display: block; color: rgb(48,44,42); font-size: 20px; margin-bottom: 8px; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"><strong style="display: inline-block; margin-right: 10px;">Sjögren's Disease Patient Conference</strong><span style="display: inline-block; vertical-align: middle;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/online2.png" style="width: 16px; height: 18px; margin: 0 0 0 6px; vertical-align: middle;"/><span style="color: rgb(6,125,143); vertical-align: middle; font-size: 16px;">Online</span></span></span><span style="display: block; color: #666; font-size: 16px; margin-bottom: 8px; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"> Sjögren's Foundation • Reston, VA </span><div style="margin-top: 12px;"><a href="https://www.facebook.com/1024838096347853/posts/1067902895374706?utm_source=sjögren's-syndrome-insights&utm_content=online-event&utm_topic=educational" rel="noopener noreferrer" style="display: inline-flex; align-items: center; padding: 8px 16px; background-color: rgb(6,125,143); color: white; text-decoration: none; border-radius: 20px; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important; font-size: 13px; margin-right: 12px; transition: all 0.2s ease; border: 2px solid rgb(6,125,143);" target="_blank"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/info.png" style="width: 16px; height: 16px; margin-right: 6px;"/> More Info </a><a href="https://healthspotlight-newsletters.s3.amazonaws.com/calendar_events/sjögren_s_disease_patient_conference-sjögren_s_foundation-20250411.ics?utm_source=sjögren's-syndrome-insights&utm_content=online-event&utm_topic=educational" style="display: inline-flex; align-items: center; padding: 8px 16px; border: 2px solid rgb(6,125,143); color: rgb(6,125,143); text-decoration: none; border-radius: 20px; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important; font-size: 13px; transition: all 0.2s ease;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/calendar2.png" style="width: 16px; height: 16px; margin-right: 6px;"/> Add to Calendar </a></div></div></td></tr></table></td></tr></div></td></tr><tr><td style="padding: 30px 0;"></td></tr><tr><td style="padding: 0 0 20px 0;"><div style="text-align: center;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle; margin-right: -5px;"></div><a href="https://www.allmyhealth.io/work-with-us?utm_tag=community-waitlist&utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="display: inline-block; padding: 8px 16px; background-color: white; color: rgb(6,125,143); text-decoration: none; border-radius: 10px; font-family: Roboto, Arial, sans-serif; font-size: 14px; border: 1px solid rgb(6,125,143); margin: 0; font-weight: bold;" target="_blank"> Advertise with us </a><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle; margin-left: -5px;"></div></div></td></tr></table></div></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=83be92df-8f8c-4884-8dc8-5410e2861989&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Sjögren&#39;s Syndrome Insights</title>
  <description>This week&#39;s must-know community updates, latest research &amp; events</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/02042025</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/02042025</guid>
  <pubDate>Wed, 02 Apr 2025 18:00:00 +0000</pubDate>
  <atom:published>2025-04-02T18:00:00Z</atom:published>
    <category><![CDATA[Newsletter]]></category>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><div class="custom_html"><table role="presentation" style="width: 100%; max-width: 600px; margin: 0 auto; background-color: #f6f4f2; overflow: hidden; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Top Stories</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><a href="https://www.sportbible.com/tennis/venus-serena-williams-diet-incurable-disease-529868-20250327?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=news&utm_topic=personal-stories" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgb(235,232,230); border-left: 4px solid rgb(6,125,143); transition: background 0.2s ease;"><div style="color: rgb(48,44,42); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Venus Williams Changes Diet for Sjögren's Syndrome</div><div style="margin: 0; line-height: 1.6; color: #444; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">Venus Williams adapted her diet to manage Sjögren's syndrome, switching to a plant-based diet to alleviate symptoms like fatigue. Her sister Serena also made dietary changes to support her.</div><span style="color: rgb(6,125,143); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a><a href="https://sjogrenssyndromenews.com/news/connect-learn-thrive-sjogrens-awareness-month-foundation/?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=news&utm_topic=community-engagement" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgb(235,232,230); border-left: 4px solid rgb(6,125,143); transition: background 0.2s ease;"><div style="color: rgb(48,44,42); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Sjögren's Awareness Month Focuses on Community Engagement</div><div style="margin: 0; line-height: 1.6; color: #444; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">During April, the Sjögren's Foundation encourages people to share their experiences and connect with others to raise awareness about living with Sjögren's Syndrome. The foundation features patient stories daily to highlight the diverse impacts of the condition.</div><span style="color: rgb(6,125,143); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; text-align: justify">Latest Research</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><div style="margin-bottom: 0px 20px 20px 20px; padding: 20px;"><div style="margin: 0; line-height: 1.6; color: #444; text-align: justify; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">Paeoniflorin, a key component of total glucosides of white paeony, has been explored for its therapeutic effects on Sjögren's syndrome. It inhibits the NLRP3 inflammasome activation in submandibular gland cells by activating the Nrf2/HO-1 pathway, which is crucial for reducing inflammation and oxidative stress. <br/><br/> This research suggests that paeoniflorin could offer a promising approach to alleviating symptoms associated with Sjögren's syndrome by targeting specific cellular mechanisms. It may contribute to developing more effective treatments, potentially improving the quality of life for those affected <a href="https://www.sciencedirect.com/science/article/pii/S0891584925001935?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="color: rgb(6,125,143) !important; text-decoration: none;" target="_blank"><span style="color: rgb(6,125,143);"><strong>(Jiang et al., 2025)</strong></span></a>.</div></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Clinical Trials</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><div style="margin: 0 20px 25px; text-align: justify; color: rgb(48,44,42); font-size: 16px; line-height: 1.6;"> This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks: </div><div style="margin: 0 20px;"><a href="https://clinicaltrials.gov/study/NCT06312020?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=phase-ii" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,0.75); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase II</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">17 countries</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18 - 75 Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">262</div></td></tr></table></div></a><a href="https://clinicaltrials.gov/study/NCT06104124?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=phase-iii" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,1); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase III</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">28 countries</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18+ Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">621</div></td></tr></table></div></a><a href="https://clinicaltrials.gov/study/NCT06245408?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=phase-iii" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,1); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase III</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">27 countries</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18+ Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">435</div></td></tr></table></div></a><a href="https://clinicaltrials.gov/study/NCT06771427?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=observational" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: white; color: #333; display: inline-block; font-size: 13px; font-weight: 500;">Observational</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">Taiwan</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">20 - 75 Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">220</div></td></tr></table></div></a><div style="text-align: left; margin-top: 30px; margin-bottom: 20px;"><a href="https://clinicaltrials.gov/search?cond=Sj%C3%B6gren%27s%20Syndrome&aggFilters=status:rec&utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=trials&utm_topic=all-trials" rel="noopener noreferrer" style="color: rgb(6,125,143); text-decoration: none; font-weight: bold; font-size: 15px;" target="_blank"> View the full list of clinical trials → </a></div></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Community News</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><a href="https://www.facebook.com/1024838096347853/posts/1066713862160276?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=patient-resources" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Apr 01, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">Sjögren’s disease is one of the most prevalent yet underrecognized autoimmune diseases, affecting millions of people worldwide. Despite its impact, awareness remains low, and many patients experience delays in diagnosis and a lack of treatment options.<br/><br/>This month, we invite you to Connect, Learn and Thrive. Connect with the Sjögren’s community,<br/><br/>Learn more about the disease and ways to bring awareness to its impact, and Thrive by accessing resources and support that empower you to live your best life with Sjögren’s.<br/><br/>Click the link below to learn more about Sjögren's Awareness Month:<br/><br/><strong style="color: rgb(6,125,143);">https://www.sjogrens.org/sjogrensmonth</strong><br/><br/><strong style="color: rgb(6,125,143);">#ThisIsSjögrens</strong></p><div style="width: 100%; margin: 20px 0; border-radius: 5px;"><img alt="Sjögren's Foundation Post" src="https://healthspotlight-newsletters.s3.amazonaws.com/post_images/6067e0be-a2bd-4309-867e-a0cab7759354-20250402-1" style="width: 100%; height: auto; display: block;"/></div></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><a href="https://www.facebook.com/1024838096347853/posts/1063856985779297?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=news-and-updates" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Mar 28, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">New Blog Alert: The Rise of Autoimmune Diseases<br/><br/>Autoimmune disease arises when the body loses the ability to distinguish between its own components (like proteins and nucleic acids) and foreign substances (like viruses), and ultimately, attacks its own healthy cells and tissues. There are over 100 types of autoimmune diseases, including Sjögren’s, system lupus erythematosus (lupus), rheumatoid arthritis, and type 1 diabetes. Due to the dysregulation of the immune system and its complex, overlapping signaling pathways, approximately 25% of people who develop an autoimmune disease will develop another.<br/><br/>Click the link below to read more:<br/><br/><strong style="color: rgb(6,125,143);">https://sjogrens.org/blog/2025/the-rise-of-autoimmune-diseases</strong></p></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><a href="https://www.facebook.com/1038746394958913/posts/1081795870653965?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=news-and-updates" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Beyond Sjögren's" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/108469241318499.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Beyond Sjögren's</strong><span style="color: #999; font-size: 14px; display: block;">Apr 01, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">April is Sjögren's Awareness Month, and we want to take this opportunity to bring awareness to the challenges that people with Sjögren's suffer with:<br/><br/>👉 What is Sjögren's?<br/><br/>Sjögren's is a relatively common autoimmune disease that is most commonly known for damaging moisture producing glands - like tear and saliva glands - causing severe dry eyes and/or mouth.<br/><br/>However, the disease often impacts far more these glands, and can affect the whole body, causing deilitating fatigue, digestive issues, joint and nerve pain, brain fog and more.<br/><br/>👉 How does it affect those who suffer with it?<br/><br/>- They often live with a deep exhaustion that doesn’t improve with rest and can make even the simplest tasks feel overwhelming.<br/><br/>- Joint pain, nerve pain, and muscle aches are common and may come and go unpredictably.<br/><br/>- Many also experience brain fog, which makes it difficult to concentrate, find the right words, or think clearly.<br/><br/>- The disease can also affect the gut, pancreas, liver, and nutrient absorption, leading to digestive and nutritional challenges.<br/><br/>- Since it’s an invisible illness, this can bring emotional strain, including feelings of isolation, misunderstanding, and the pressure to keep going despite everything.<br/><br/>- Flare-ups often strike without warning, making it difficult to plan ahead or keep up with daily life.<br/><br/>- Most people spend years searching for answers before finally receiving a diagnosis.<br/><br/>- Many also experience dismissal or a lack of support from health professionals, often due to how nonspecific or misunderstood the symptoms can be.<br/><br/>Despite how life-altering it can be, and how relatively common it is, Sjögren’s receives far less funding and public attention compared to other autoimmune conditions.<br/><br/>People with Sjögren’s deserve to be seen, heard and supported. Let’s hope we can move closer to that goal this April.<br/><br/>Share this post to raise awareness!<br/><br/>--</p></div></a><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">Upcoming Events</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div></td></tr><tr><td><table style="width: 100%; max-width: 600px; margin-bottom: 28px; padding-top: 20px; border: none; border-collapse: separate; overflow: hidden;"><tr><td rowspan="1" style="width: 110px; text-align: center; vertical-align: top; padding: 0; border: none; padding-bottom: 40px;"><table style="width: 110px; border: 3px solid rgb(6,125,143); border-radius: 18px; background: #f6f4f2; border-collapse: separate; overflow: hidden;"><tr><td style="background: rgb(6,125,143); color: white; text-align: center; padding: 8px 0; font-weight: bold; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important; border-radius: 15px 15px 0 0; font-size: 16px;"> APR </td></tr><tr><td style="text-align: center; padding: 8px 0; font-size: 36px; font-weight: bold; color: rgb(6,125,143); font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"> 11 </td></tr></table></td><td style="padding: 0 0 40px 20px; border: none; vertical-align: top;"><div style="margin: 0;"><span style="display: block; color: rgb(48,44,42); font-size: 20px; margin-bottom: 8px; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"><strong style="display: inline-block; margin-right: 10px;">Sjögren's Patient Conference</strong><span style="display: inline-block; vertical-align: middle;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/online2.png" style="width: 16px; height: 18px; margin: 0 0 0 6px; vertical-align: middle;"/><span style="color: rgb(6,125,143); vertical-align: middle; font-size: 16px;">Online</span></span></span><span style="display: block; color: #666; font-size: 16px; margin-bottom: 8px; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"> Sjögren's Foundation • Reston, VA </span><div style="margin-top: 12px;"><a href="https://www.facebook.com/1024838096347853/posts/1062330709265258?utm_source=sjögren's-syndrome-insights&utm_content=online-event&utm_topic=educational" rel="noopener noreferrer" style="display: inline-flex; align-items: center; padding: 8px 16px; background-color: rgb(6,125,143); color: white; text-decoration: none; border-radius: 20px; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important; font-size: 13px; margin-right: 12px; transition: all 0.2s ease; border: 2px solid rgb(6,125,143);" target="_blank"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/info.png" style="width: 16px; height: 16px; margin-right: 6px;"/> More Info </a><a href="https://healthspotlight-newsletters.s3.amazonaws.com/calendar_events/sjögren_s_patient_conference-sjögren_s_foundation-20250411.ics?utm_source=sjögren's-syndrome-insights&utm_content=online-event&utm_topic=educational" style="display: inline-flex; align-items: center; padding: 8px 16px; border: 2px solid rgb(6,125,143); color: rgb(6,125,143); text-decoration: none; border-radius: 20px; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important; font-size: 13px; transition: all 0.2s ease;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/calendar2.png" style="width: 16px; height: 16px; margin-right: 6px;"/> Add to Calendar </a></div></div></td></tr></table></td></tr></div></td></tr><tr><td style="padding: 30px 0;"></td></tr><tr><td style="padding: 0 0 20px 0;"><div style="text-align: center;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle; margin-right: -5px;"></div><a href="https://www.allmyhealth.io/work-with-us?utm_tag=community-waitlist&utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="display: inline-block; padding: 8px 16px; background-color: white; color: rgb(6,125,143); text-decoration: none; border-radius: 10px; font-family: Roboto, Arial, sans-serif; font-size: 14px; border: 1px solid rgb(6,125,143); margin: 0; font-weight: bold;" target="_blank"> Advertise with us </a><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle; margin-left: -5px;"></div></div></td></tr></table></div></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=171c0c24-3a2d-4c15-bfef-5ba043a1621d&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Sjögren&#39;s Syndrome Insights</title>
  <description>This week&#39;s must-know community updates, latest research &amp; events</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/19032025</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/19032025</guid>
  <pubDate>Wed, 19 Mar 2025 18:00:00 +0000</pubDate>
  <atom:published>2025-03-19T18:00:00Z</atom:published>
    <category><![CDATA[Newsletter]]></category>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><div class="custom_html"><table role="presentation" style="width: 100%; max-width: 600px; margin: 0 auto; background-color: #f6f4f2; overflow: hidden; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"><tr><td style="padding: 0;"><div style="background-color: rgb(235,232,230); padding: 30px; margin-top: 30px; margin-bottom: 30px; border-radius: 8px; box-shadow: 0 2px 5px rgba(0,0,0,0.1); font-family: Arial, sans-serif;"><a href="https://www.allmyhealth.io/reports/an-introduction-to-gene-therapy?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" style="text-decoration: none;" target="_blank"><h2 style="color: rgb(48,44,42); font-size: 24px; margin: 0; font-weight: 700; margin-bottom: 25px; line-height: 1.3; text-align: center;">Introduction to Gene Therapy - out now!</h2><table role="presentation" style="width: 100%;"><tr><td style="width: 60%; padding-right: 40px; vertical-align: top;"><p style="color: #555; font-size: 15px; margin: 10px 0; line-height: 1.5;">We're thrilled to announce the launch of the first guide in our gene & cell therapy series.</p><p style="color: #555; font-size: 15px; margin-top: 5px; margin-bottom: 2px; line-height: 1.5;">Read it for free here:</p><span style="color: rgb(6,125,143); font-size: 15px; text-decoration: none; font-weight: 500; display: inline-block;">www.allmyhealth.io/reports</span><p style="color: #555; font-size: 15px; margin-top: 18px; line-height: 1.6;">Stay tuned for next week when we will launch the next report in the series.</p><p style="color: #555; font-size: 15px; margin-top: 18px; line-height: 1.6;">Would you like to sponsor the next report in the series?</p></td><td style="width: 40%; vertical-align: top;"><img alt="Report Thumbnail" src="https://framerusercontent.com/images/LzCXPDC59DthtrU10XKfEgzHzw.png" style="width: auto; height: 260px; border-radius: 8px; box-shadow: 0 3px 10px rgba(0,0,0,0.15);"/></td></tr></table></a><a href="https://www.allmyhealth.io/sponsorship-opportunity?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" style="display: inline-block; background-color: rgb(6,125,143); color: white; text-decoration: none; padding: 12px 24px; border-radius: 6px; margin-top: 20px; font-weight: 600; font-size: 15px; transition: background-color 0.3s ease;">Enquire here</a></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Top Stories</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><a href="https://www.healio.com/news/rheumatology/20250318/nipocalimab-nets-fda-fasttrack-designation-for-sjgrens-disease?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=news&utm_topic=clinical-breakthroughs" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgb(235,232,230); border-left: 4px solid rgb(6,125,143); transition: background 0.2s ease;"><div style="color: rgb(48,44,42); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Nipocalimab receives FDA Fast Track designation for Sjögren's Syndrome.</div><div style="margin: 0; line-height: 1.6; color: #444; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">Nipocalimab has shown significant improvement in reducing symptoms of Sjögren's Syndrome, with a notable decrease in systemic disease activity. This development accelerates its path to potential approval, addressing a significant need for effective treatments.</div><span style="color: rgb(6,125,143); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a><a href="https://sjogrenssyndromenews.com/news/nearly-80-women-sjogrens-experience-sexual-dysfunction-study/?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=news&utm_topic=clinical-breakthroughs" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgb(235,232,230); border-left: 4px solid rgb(6,125,143); transition: background 0.2s ease;"><div style="color: rgb(48,44,42); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Most Women with Sjögren's Experience Sexual Dysfunction</div><div style="margin: 0; line-height: 1.6; color: #444; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">Women with Sjögren's often face challenges like vaginal dryness and low satisfaction, affecting their quality of life. These symptoms highlight the need for comprehensive care that includes sexual health assessments.</div><span style="color: rgb(6,125,143); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; text-align: justify">Latest Research</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><div style="margin-bottom: 0px 20px 20px 20px; padding: 20px;"><div style="margin: 0; line-height: 1.6; color: #444; text-align: justify; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">In a systematic review and meta-analysis, <a href="https://www.tandfonline.com/doi/full/10.1080/09638288.2025.2474085?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=research&utm_topic=patient-outcomes&af=R" rel="noopener noreferrer" style="color: rgb(6,125,143) !important; text-decoration: none;" target="_blank"><strong>Nacar et al. (2025)</strong></a> examined the impact of exercise on individuals with primary Sjögren's syndrome. The study focused on outcomes such as pain, fatigue, quality of life, disease activity, aerobic capacity, and dryness. The analysis included randomized clinical trials to determine the effectiveness of different types of exercise interventions.<br/><br/> The findings revealed that exercise led to improvements in several areas. Notably, participants reported reduced pain and fatigue, enhanced quality of life, and increased aerobic capacity. However, the study did not find significant changes in disease activity or dryness symptoms. The research suggests that exercise can be a beneficial complementary therapy for managing certain symptoms of primary Sjögren's syndrome, although the most effective type of exercise was not conclusively determined.</div></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Clinical Trials</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><div style="margin: 0 20px 25px; text-align: justify; color: rgb(48,44,42); font-size: 16px; line-height: 1.6;"> This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks: </div><div style="margin: 0 20px;"><a href="https://clinicaltrials.gov/study/NCT06747949?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,1); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase III</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">United States</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18+ Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">844</div></td></tr></table></div></a><a href="https://clinicaltrials.gov/study/NCT06245408?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,1); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase III</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">27 countries</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18+ Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">435</div></td></tr></table></div></a><a href="https://clinicaltrials.gov/study/NCT05946941?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: rgba(6,125,143,1); color: white; display: inline-block; padding: 2px 8px; border-radius: 4px; width: fit-content; font-size: 12px; font-weight: 500">Phase III</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">34 countries</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18+ Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">756</div></td></tr></table></div></a><a href="https://clinicaltrials.gov/study/NCT03003572?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="margin-bottom: 20px; background-color: white; border-radius: 8px; box-shadow: 0 2px 4px rgba(0,0,0,0.1); overflow: hidden; text-decoration: none; color: inherit; display: block;" target="_blank"><div style="padding: 12px 16px; border-bottom: 1px solid #f0f0f0;"><div style="display: flex; align-items: flex-start;"><div style="color: rgb(48,44,42); font-weight: bold; font-size: 16px; line-height: 1.4; flex: 1;"> Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity </div></div></div><div style="padding: 12px 16px;"><table style="width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Study Type</div><div style="background-color: white; color: #333; display: inline-block; font-size: 13px; font-weight: 500;">Observational</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Location</div><div style="font-size: 13px; color: #333; font-weight: 500;">France</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Age Range</div><div style="font-size: 13px; color: #333; font-weight: 500;">18+ Years</div></td><td style="width: 25%; padding: 8px;"><div style="font-size: 12px; color: #777; margin-bottom: 4px;">Enrollment</div><div style="font-size: 13px; color: #333; font-weight: 500;">185</div></td></tr></table></div></a><div style="text-align: left; margin-top: 30px; margin-bottom: 20px;"><a href="https://clinicaltrials.gov/search?cond=Sj%C3%B6gren%27s+Syndrome&aggFilters=status%3Arec&utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="color: rgb(6,125,143); text-decoration: none; font-weight: bold; font-size: 15px;" target="_blank"> View the full list of clinical trials → </a></div></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Community News</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><a href="https://www.facebook.com/1024838096347853/posts/1054959036669092?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=patient-survey" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Mar 17, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">According to the 2021 Living With Sjögren's Patient Survey 65% of Sjögren's patients report experiencing frequent headaches and 32% of Sjögren’s patients have been diagnosed with migraines.</p><div style="width: 100%; margin: 20px 0; border-radius: 5px;"><img alt="Sjögren's Foundation Post" src="https://healthspotlight-newsletters.s3.amazonaws.com/post_images/6067e0be-a2bd-4309-867e-a0cab7759354-20250319-1" style="width: 100%; height: auto; display: block;"/></div></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><a href="https://www.facebook.com/1024838096347853/posts/1052431246921871?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=personal-stories" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Mar 14, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">The Sjögren's Foundation is thrilled to celebrate Kathy Hammitt, our VP of Medical and Scientific Affairs, as the recipient of the 2025 Jack Hein Public Service Award from American Association for Dental, Oral, and Craniofacial Research (AADOCR)! Kathy has dedicated her career to advancing Sjögren’s disease research and advocating for patients—work that has transformed care, clinical trials, and awareness.<br/><br/>Join us in congratulating Kathy on this well-deserved recognition!<br/><br/>Click the link below to read more:<br/><br/><strong style="color: rgb(6,125,143);">https://sjogrens.org/blog/2025/a-lifetime-of-advocacy-recognized-sjogrens-foundation-leader-kathy-hammitt-receives-the</strong></p></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><a href="https://www.facebook.com/1038746394958913/posts/1066256732207879?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=personal-stories" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Beyond Sjögren's" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/108469241318499.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Beyond Sjögren's</strong><span style="color: #999; font-size: 14px; display: block;">Mar 14, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">With all the craziness that is going in the world, it’s completely normal to want to stay informed. Following the news can give us a sense of control - something much needed when suffering the unpredictability of Sjögren's and its symptoms.<br/><br/>However... continuously following stressful news stories can weigh heavily on us, increasing stress and anxiety—which, as you know, can directly impact symptoms and overall well-being.<br/><br/>It can also limit your ability to connect meaningfully with the people around you and your local community - connections that are deeply healing and supportive.<br/><br/>Your energy is precious! So using it to nurture your health, connect deeply with others, and make a meaningful difference in your local community can bring you more peace and fulfilment into your life.<br/><br/>It’s okay to prioritise your mental and emotional well-being by setting healthy boundaries around news consumption. When you feel better, you'll be better able to support yourself, your loved ones, and your local community.<br/><br/>💬 Have you noticed a difference in how you feel when you step back from constant news updates? Let us know your experience below</p></div></a><tr><td style="padding: 0 0 20px 0;"><div style="text-align: center;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle; margin-right: -5px;"></div><a href="https://www.allmyhealth.io/work-with-us?utm_tag=community-waitlist&utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="display: inline-block; padding: 8px 16px; background-color: white; color: rgb(6,125,143); text-decoration: none; border-radius: 10px; font-family: Roboto, Arial, sans-serif; font-size: 14px; border: 1px solid rgb(6,125,143); margin: 0; font-weight: bold;" target="_blank"> Advertise with us </a><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle; margin-left: -5px;"></div></div></td></tr></div></td></tr></table></div></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=9f699aeb-1959-4f4d-abd9-4995e6649e61&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Sjögren&#39;s Syndrome Insights</title>
  <description>Apply now: feature your voice in our cell and gene therapy series</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/06032025</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/06032025</guid>
  <pubDate>Fri, 07 Mar 2025 12:00:00 +0000</pubDate>
  <atom:published>2025-03-07T12:00:00Z</atom:published>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><div class="custom_html"><table role="presentation" style="width: 100%; max-width: 600px; margin: 0 auto; background-color: #f6f4f2; overflow: hidden; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"><tr><td style="padding: 15px 0px;"></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; text-align: justify">Don't miss out!</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><div style="margin-bottom: 0px 20px 20px 20px; padding: 20px;"><div style="margin: 0; line-height: 1.6; color: #444; text-align: justify; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">Thank you to everyone who has <a href="https://forms.gle/uLv39JF2Uf2B2B6D8?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="color: rgb(6,125,143) !important; text-decoration: none;" target="_blank"><span style="color: rgb(6,125,143);"><strong>completed our form </strong></span></a> and sent in questions they would like us to answer, and to those who would like to partner with us in sponsoring, contributing and distributing the cell and gene therapy guide. <br/><br/><strong>We would love to hear from more of you in this community and still have some partner slots left so please reach out asap by clicking below👇!</strong></div></div></div></td></tr><tr><td style="padding: 15px 0;"></td></tr><tr><td style="padding: 0px 0px 30px 0px;"><div style="border: 2px solid rgb(6,125,143); border-radius: 15px;"><div style="background-color: rgb(6,125,143); border-radius: 10px 10px 0px 0px; padding: 15px; text-align: center; color: white; font-size: 18px; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important; font-weight: bold;"> Apply now: feature your voice in our cell & gene therapy series </div><div style="background-color: #f6f4f2; padding: 20px; margin-top: 2px; border-radius: 15px; font-family: Arial, sans-serif; text-align: center; "><div style="color: rgb(48,44,42); font-size: 16px; line-height: 1.5; text-align: left; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"> Cell and gene therapies are transforming rare disease treatment, offering new hope where options were once limited. But how do they work, and what choices exist for your community? </div><div style="margin-top: 10px; color: rgb(48,44,42); font-size: 16px; line-height: 1.5; text-align: justify; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"> We're launching a special content series to help our 15k+ readers navigate this evolving landscape – and we need your voice! </div><div style="margin-top: 20px; font-size: 16px; color: rgb(48,44,42); text-align: left;"><strong>Be part of the conversation, whether you are: </strong></div><div style="margin: 15px 0 0 20px; padding: 0; color: rgb(48,44,42); font-size: 16px; text-align: left;"><div style="margin-top: 10px;">•   A patient or carer</div><div style="margin-top: 10px;">•   A patient support group</div><div style="margin-top: 10px;">•   Developing cell & gene therapies</div><div style="margin-top: 10px;">•   Administering cell & gene therapies</div></div></div><div style="margin-top: 20px; color: rgb(48,44,42); font-size: 16px; font-weight: bold; text-align: center;"> 📅 Enquiries close: March 12 </div><div style="margin-top: 20px; display: flex; justify-content: center;"><a href="https://forms.gle/AR33Wp1gVJAmo3xJ6?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" style="text-decoration: none;" target="_blank"><div style="background-color: rgb(6,125,143); color: white; padding: 15px 30px; border-radius: 5px; font-size: 16px; font-weight: bold; text-align: center;">Register your interest</div></a></div><div style="margin-top: 20px; font-weight: bold; font-size: 16px; color: rgb(48,44,42); text-align: center;"> Let's educate, advocate and drive change together. </div><div style="margin-bottom: 20px"></div></div></td></tr></table></div></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=4999785d-e00e-41ae-abdd-9272990ec489&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Sjögren&#39;s Syndrome Insights</title>
  <description>This week&#39;s must-know community updates, latest research &amp; events</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/05032025</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/05032025</guid>
  <pubDate>Wed, 05 Mar 2025 18:00:00 +0000</pubDate>
  <atom:published>2025-03-05T18:00:00Z</atom:published>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><div class="custom_html"><table role="presentation" style="width: 100%; max-width: 600px; margin: 0 auto; background-color: #f6f4f2; overflow: hidden; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"><tr><td style="padding: 20px 0px;"><a href="https://www.linkedin.com/posts/all-my-health_allmyhealth-raredisease-patientempowerment-activity-7300930792346578945-qnEO?utm_source=share&utm_medium=member_desktop&rcm=ACoAADhVBJcBabaH_VWrKjIYLdVudX1BwpBcgPQ" style="text-decoration: none;" target="_blank"><div style="background-color: rgba(4, 17, 79, 0.06); padding: 15px; margin-top: 20px; border-radius: 10px; display: flex; align-items: center;"><div style="flex: 1;"><h4 style="color: rgb(48,44,42); font-size: 18px; margin: 0; font-weight:bold;">HealthSpotlight is now AllMyHealth!</h4><p style="color: #555; font-size: 14px; margin: 15px 0;">Read all about our exciting merger <strong>here</strong>.</p></div><div style="flex-shrink: 0; margin-left: 20px;"><img alt="Report Thumbnail" src="https://beehiiv-images-production.s3.amazonaws.com/uploads/asset/file/bfa3fd16-6a7e-4d41-926f-158e50d456dd/image.png?t=1741179443" style="width: 125px; height: auto; border-radius: 15px;"/></div></div></a></td></tr><tr><td style="padding: 0px 0px 30px 0px;"><div style="border: 2px solid rgb(6,125,143); border-radius: 15px;"><div style="background-color: rgb(6,125,143); border-radius: 10px 10px 0px 0px; padding: 15px; text-align: center; color: white; font-size: 18px; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important; font-weight: bold;"> Apply now: feature your voice in our cell & gene therapy series </div><div style="background-color: #f6f4f2; padding: 20px; margin-top: 2px; border-radius: 15px; font-family: Arial, sans-serif; text-align: center; "><div style="color: rgb(48,44,42); font-size: 16px; line-height: 1.5; text-align: left; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"> Cell and gene therapies are transforming rare disease treatment, offering new hope where options were once limited. But how do they work, and what choices exist for your community? </div><div style="margin-top: 10px; color: rgb(48,44,42); font-size: 16px; line-height: 1.5; text-align: justify; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;"> We're launching a special content series to help our 15k+ readers navigate this evolving landscape – and we need your voice! </div><div style="margin-top: 20px; font-size: 16px; color: rgb(48,44,42); text-align: left;"><strong>Be part of the conversation, whether you are: </strong></div><div style="margin: 15px 0 0 20px; padding: 0; color: rgb(48,44,42); font-size: 16px; text-align: left;"><div style="margin-top: 10px;">•   A patient or carer</div><div style="margin-top: 10px;">•   A patient support group</div><div style="margin-top: 10px;">•   Developing cell & gene therapies</div><div style="margin-top: 10px;">•   Administering cell & gene therapies</div></div></div><div style="margin-top: 20px; color: rgb(48,44,42); font-size: 16px; font-weight: bold; text-align: center;"> 📅 Enquiries close: March 12 </div><div style="margin-top: 20px; display: flex; justify-content: center;"><a href="https://forms.gle/AR33Wp1gVJAmo3xJ6?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" style="text-decoration: none;" target="_blank"><div style="background-color: rgb(6,125,143); color: white; padding: 15px 30px; border-radius: 5px; font-size: 16px; font-weight: bold; text-align: center;">Register your interest</div></a></div><div style="margin-top: 20px; font-weight: bold; font-size: 16px; color: rgb(48,44,42); text-align: center;"> Let's educate, advocate and drive change together. </div><div style="margin-bottom: 20px"></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Top Stories</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><a href="https://www.biospace.com/business/kiniksa-axes-sjogrens-program-astrazeneca-licensed-antibody-in-cardio-pivot?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=news&utm_topic=pharmaceutical-insights" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgb(235,232,230); border-left: 4px solid rgb(6,125,143); transition: background 0.2s ease;"><div style="color: rgb(48,44,42); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Kiniksa Ends Sjögren's Program, Focuses on Cardio</div><div style="margin: 0; line-height: 1.6; color: #444; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">Kiniksa Pharmaceuticals is stopping development of abiprubart, a potential treatment for Sjögren's syndrome, to focus on cardiovascular therapies. This decision ends their involvement with this syndrome, leaving other companies like Kronos Bio to explore new treatments.</div><span style="color: rgb(6,125,143); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; text-align: justify">Latest Research</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><div style="margin-bottom: 0px 20px 20px 20px; padding: 20px;"><div style="margin: 0; line-height: 1.6; color: #444; text-align: justify; font-family: Inter, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif !important;">In a recent study published by the <a href="https://www.dovepress.com/updating-on-the-dual-role-of-salivary-gland-epithelial-cell-sgec-in-sj-peer-reviewed-fulltext-article-JIR?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=research&utm_topic=preclinical-discoveries" rel="noopener noreferrer" style="color: rgb(6,125,143) !important; text-decoration: none;" target="_blank"><strong>Journal of Inflammation Research (2025)</strong></a>, researchers have highlighted the complex role of Salivary Gland Epithelial Cells (SGEC) in Sjögren's disease. SGECs are not only victims of autoimmune injury but also play a significant role in saliva secretion. The study delves into how these cells can both protect against and contribute to the disease's progression. It emphasizes the importance of understanding the balance of calcium, endoplasmic reticulum, and mitochondrial homeostasis in SGECs, as well as the impact of Pattern Recognition Receptors and programmed cell death on these cells. <br/><br/> The findings suggest that targeting SGECs could be a promising approach to treating Sjögren's disease by addressing the inflammatory response in the salivary glands. This underscores the need for further research to fully understand the dual role of SGECs and develop effective treatments that can restore salivary gland function and improve patients' quality of life.</div></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div><h2 style="color: rgb(6,125,143); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Community News</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><div><a href="https://www.facebook.com/1024838096347853/posts/1043401041158225?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=patient-survey" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Mar 03, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">According to our 2021 Living with Sjögren's Patient Survey 82% of Sjögren's patients experience joint pain and 72% of Sjögren’s patients experience muscle pain.</p><div style="width: 100%; margin: 20px 0; border-radius: 5px;"><img alt="Sjögren's Foundation Post" src="https://healthspotlight-newsletters.s3.amazonaws.com/post_images/6067e0be-a2bd-4309-867e-a0cab7759354-20250305-1" style="width: 100%; height: auto; display: block;"/></div></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><a href="https://www.facebook.com/1024838096347853/posts/1044368964394766?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=patient-resources" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Mar 04, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;"><strong style="color: rgb(6,125,143);">#TipTuesday:</strong> When preparing for surgery, provide your physician with a final list of medications you will bring to the hospital. Ask your doctor if an order can be included on your chart stating that you may take these medications on your own.<br/><br/>We encourage you to share this tip on your page and comment below with your experience(s).</p><div style="width: 100%; margin: 20px 0; border-radius: 5px;"><img alt="Sjögren's Foundation Post" src="https://healthspotlight-newsletters.s3.amazonaws.com/post_images/6067e0be-a2bd-4309-867e-a0cab7759354-20250305-2" style="width: 100%; height: auto; display: block;"/></div></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle;"></div></div><a href="https://www.facebook.com/1038746394958913/posts/1054431436723742?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=patient-resources" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: white; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Beyond Sjögren's" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/108469241318499.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(48,44,42); font-size:18px; display: block;">Beyond Sjögren's</strong><span style="color: #999; font-size: 14px; display: block;">Feb 27, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">Although hair loss is not a direct symptom of Sjögren’s, it can be a side effect of the condition and its complications, and many people with Sjögren’s can experience hair thinning or increased shedding due to underlying factors linked to the disease, let's explore what they are.<br/><br/>➡️ Several factors can lead to hair loss in Sjögren's, including:<br/><br/>- Thyroid dysfunction & hormonal imbalances, which can often overlap with Sjögren's.<br/><br/>- Chronic inflammation disrupting the hair growth cycle, leading to increased shedding.<br/><br/>- Nutrient deficiencies, including Vitamin D, B, omega 3s and others which are essential for hair health.<br/><br/>- Reduced oil production, which can lead to a dry, irritated scalp and brittle hair.<br/><br/>- Some medications used for Sjögren’s, which can list hair loss as a side effect.<br/><br/>- Chronic stress, which can disrupt the hair growth cycle.<br/><br/>➡️ How can you promote healthy hair growth?<br/><br/>1️⃣ Do regular scalp massages, as studies show they can help increase hair thickness and reduce hair thinning.<br/><br/>2️⃣ Use gentle, sulfate-free shampoos and light oils like argan or jojoba to protect hair strands.<br/><br/>3️⃣ Do your best to manage stress, as chronic stress impacts hormone balance and increases inflammation.<br/><br/>4️⃣ Try your best to follow a whole foods anti-inflammatory diet, which will help address deficiencies and reduce inflammation.<br/><br/>5️⃣ If hair loss persists, consider getting tested for other potential dysfunctions that could be impacting hair loss (such as thyroid dysfunction).<br/><br/>💡 Looking for a holistic way to improve your health?<br/><br/>We have recently launched a program to help people improve their health and address their Sjögren's symptoms through a natural approach, based on what has helped our 1-1 clients.<br/><br/>The program gathers the tools and strategies needed to support your body to heal, balance inflammation, and improve symptoms in a clear step-by-step method.<br/><br/>💬 DM or comment ‘PROGRAM’ for more info!</p></div></a></div></td></tr><tr><td style="padding: 30px 0;"></td></tr><tr><td style="padding: 40px 30px; background-color: rgba(6,125,143,0.1); border-radius: 10px; margin: 20px 0;"><div style="text-align: center;"><h2 style="color: rgb(6,125,143); font-size: 24px; margin-bottom: 15px;">Click Here to Join Our Community </h2><a href="mailto:info@allmyhealth.io" rel="noopener noreferrer" style="display: inline-block; padding: 12px 30px; background-color: rgb(6,125,143); color: white; text-decoration: none; border-radius: 25px; font-family: Roboto, Arial, sans-serif; font-size: 16px; font-weight: bold;" target="_blank"> Join Our Waitlist </a></div></td></tr><tr><td style="padding: 30px 0;"></td></tr><tr><td style="padding: 0 0 20px 0;"><div style="text-align: center;"><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle; margin-right: -5px;"></div><a href="https://www.allmyhealth.io/contact-us?utm_tag=community-waitlist&utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="display: inline-block; padding: 8px 16px; background-color: white; color: rgb(6,125,143); text-decoration: none; border-radius: 10px; font-family: Roboto, Arial, sans-serif; font-size: 14px; border: 1px solid rgb(6,125,143); margin: 0; font-weight: bold;" target="_blank"> Advertise with us </a><div style="display: inline-block; width: 40px; height: 1px; background: rgb(6,125,143); vertical-align: middle; margin-left: -5px;"></div></div></td></tr></table></div></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=48a7a450-bde1-409e-9746-dd447d262a1c&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Sjögren&#39;s Syndrome Insights</title>
  <description>First Sjögren&#39;s Patient Receives Stem Cell Therapy</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/19022025</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/19022025</guid>
  <pubDate>Wed, 19 Feb 2025 18:00:00 +0000</pubDate>
  <atom:published>2025-02-19T18:00:00Z</atom:published>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><div class="custom_html"><table role="presentation" style="width: 100%; max-width: 600px; margin: 0 auto; background-color: white; overflow: hidden; font-family: 'Roboto', sans-serif;"><tr><td style="padding: 0px 0px 40px 0px;"><a href="mailto:editorial@healthspotlight.io" rel="noopener noreferrer" target="_blank"><img alt="Advertise with us" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/advertise_banner.jpeg" style="width: 100%; max-width: 600px; height: auto; display: block; border: 0;"/></a></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div><h2 style="color: rgb(4,14,79); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Top Stories</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div></div><div><a href="https://sjogrenssyndromenews.com/news/first-sjogrens-patient-receives-stem-cell-therapy-xerostomia/?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=news&utm_topic=clinical-breakthroughs" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgba(4,14,79,0.03); border-left: 4px solid rgb(4,14,79); transition: background 0.2s ease;"><h3 style="color: rgb(4,14,79); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">First Sjögren's Patient Receives Stem Cell Therapy</h3><p style="margin: 0; line-height: 1.6; color: #444;">This treatment aims to help people with Sjögren's Syndrome by addressing dry mouth, a common symptom, using stem cells from the patient's own bone marrow. It might reduce the need for lozenges and improve saliva production.</p><span style="color: rgb(4,14,79); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div><h2 style="color: rgb(4,14,79); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; text-align: justify">Latest Research</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div></div><div><div style="margin-bottom: 0px 20px 20px 20px; padding: 20px;"><p style="margin: 0; line-height: 1.6; color: #444; text-align: justify">The study published in <a href="https://link.springer.com/article/10.1186/s12903-025-05595-1?utm_source=sj%C3%B6gren%27s-syndrome-insights&utm_content=research&utm_topic=diagnostic-insights" rel="noopener noreferrer" style="color: rgb(4, 14, 79); text-decoration: none;" target="_blank"><strong>BMC Oral Health (2025)</strong></a> explored the relationship between the number of copies of the AMY1 gene and the severity of dry mouth conditions, including Sjögren's syndrome. The research found that higher numbers of the AMY1 gene, which is responsible for producing salivary α-amylase, an enzyme in saliva, were associated with less severe symptoms of dry mouth. <br/><br/>This suggests that the AMY1 gene copy number could serve as a genetic marker to help identify individuals at risk for these conditions early on. The significance of this finding lies in the potential for AMY1 copy number to be used as a biomarker for early detection of dry mouth-related conditions. By identifying individuals with a lower copy number of the AMY1 gene, healthcare providers could potentially intervene sooner, improving patient outcomes and quality of life.</p></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div><h2 style="color: rgb(4,14,79); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Community News</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div></div><div><a href="https://www.facebook.com/1024838096347853/posts/1033744665457196?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=personal-stories" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: #ffffff; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(4,14,79); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Feb 18, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;"><strong style="color: rgb(4,14,79);">#TipTuesday:</strong> Sjögren’s is not a “cookie cutter” disease & affects patients differently. This is why one coping technique will not work for every patient. Finding what works for YOU is a difficult but important process. Although the hallmark symptoms are dry eyes, dry mouth, fatigue and joint pain, Sjögren’s is a systemic disease and affects the entire body.<br/><br/>We encourage you to share this tip on your page and comment below with your experience(s).</p><div style="width: 100%; margin: 20px 0; border-radius: 5px;"><img alt="Sjögren's Foundation Post" src="https://healthspotlight-newsletters.s3.amazonaws.com/post_images/6067e0be-a2bd-4309-867e-a0cab7759354-20250219-1" style="width: 100%; height: auto; display: block;"/></div></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 60px; height: 1px; background: rgba(4,14,79,0.3);"></div></div><a href="https://www.facebook.com/1024838096347853/posts/1030514745780188?utm_source=sjögren's-syndrome-insights&utm_content=community" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: #ffffff; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(4,14,79); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Feb 14, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">A Very Happy Valentines Day to You From the Sjögren's Foundation ❤️</p><div style="width: 100%; margin: 20px 0; border-radius: 5px;"><img alt="Sjögren's Foundation Post" src="https://healthspotlight-newsletters.s3.amazonaws.com/post_images/6067e0be-a2bd-4309-867e-a0cab7759354-20250219-2" style="width: 100%; height: auto; display: block;"/></div></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 60px; height: 1px; background: rgba(4,14,79,0.3);"></div></div><a href="https://www.facebook.com/1038746394958913/posts/1043733971126822?utm_source=sjögren's-syndrome-insights&utm_content=community&utm_topic=patient-resources" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: #ffffff; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Beyond Sjögren's" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/108469241318499.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(4,14,79); font-size:18px; display: block;">Beyond Sjögren's</strong><span style="color: #999; font-size: 14px; display: block;">Feb 13, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">Sjögren's can put a big strain on romantic relationships.<br/><br/>From communication issues due to brain fog, to relationship issues due to changing roles, and intimacy issues due to dryness, the challenges can be many.<br/><br/>But although Sjögren's can come with many challenges, there's a lot that couples can do to strengthen their bond, work on the relationship and make their relationship a sanctuary for health rather than sickness. We hope these tips spark some loving and inspiring conversations! 💕<br/><br/>Happy Valentine's Day ❤️<br/><br/>--<br/><br/>Want to learn more?<br/><br/>Our "Healing with Sjögren’s Naturally" course includes a lesson on Relationships, helping you navigate challenges, foster understanding, set boundaries, and communicate your needs with confidence.<br/><br/>💬 DM or comment ‘Course’ for more info!</p></div></a></div></td></tr><tr><td style="padding: 30px 0;"></td></tr><tr><td style="padding: 40px 30px; background-color: rgba(4,14,79,0.05); border-radius: 10px; margin: 20px 0;"><div style="text-align: center;"><h2 style="color: rgb(4,14,79); font-size: 24px; margin-bottom: 15px;">Click Here to Join Our Community </h2><a href="mailto:editorial@healthspotlight.io?utm_tag=community-list" rel="noopener noreferrer" style="display: inline-block; padding: 12px 30px; background-color: rgb(4,14,79); color: white; text-decoration: none; border-radius: 25px; font-family: Roboto, Arial, sans-serif; font-size: 16px; font-weight: bold;" target="_blank"> Join Our Waitlist </a></div></td></tr><tr><td style="padding: 30px 0;"></td></tr><tr><td style="padding: 0 0 20px 0;"><div style="text-align: center;"><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle; margin-right: -5px;"></div><a href="https://www.allmyhealth.io/contact-us?utm_tag=community-waitlist&utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="display: inline-block; padding: 8px 16px; background-color: white; color: rgb(4,14,79); text-decoration: none; border-radius: 10px; font-family: Roboto, Arial, sans-serif; font-size: 14px; border: 1px solid rgba(4,14,79,0.3); margin: 0; font-weight: bold;" target="_blank"> Advertise with us </a><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle; margin-left: -5px;"></div></div></td></tr></table></div></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=51bd882a-0ea1-47b7-a151-9dfa92fad7d3&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Sjögren&#39;s Syndrome Insights</title>
  <description>Anti-SSA Antibodies Linked to Severe Dry Eyes</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/new-post</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/new-post</guid>
  <pubDate>Thu, 06 Feb 2025 16:00:00 +0000</pubDate>
  <atom:published>2025-02-06T16:00:00Z</atom:published>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><div class="custom_html"><table role="presentation" style="width: 100%; max-width: 600px; margin: 0 auto; background-color: white; overflow: hidden; font-family: 'Roboto', sans-serif;"><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div><h2 style="color: rgb(4,14,79); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Top Stories</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div></div><div><a href="https://sjogrenssyndromenews.com/news/anti-ssa-antibodies-tied-eye-dryness-sjogrens-study/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgba(4,14,79,0.03); border-left: 4px solid rgb(4,14,79); transition: background 0.2s ease;"><h3 style="color: rgb(4,14,79); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Anti-SSA Antibodies Linked to Severe Dry Eyes</h3><p style="margin: 0; line-height: 1.6; color: #444;">People with anti-SSA antibodies often experience more severe dry eye symptoms, including faster tear evaporation and increased inflammation. This can lead to significant eye damage and reduced vision quality.</p><span style="color: rgb(4,14,79); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a><a href="https://www.fiercebiotech.com/biotech/novartis-gives-anti-cd40-antibody-treat-sjogrens-due-benefitrisk-profile?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgba(4,14,79,0.03); border-left: 4px solid rgb(4,14,79); transition: background 0.2s ease;"><h3 style="color: rgb(4,14,79); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Novartis Drops Anti-CD40 Antibody for Sjögren's</h3><p style="margin: 0; line-height: 1.6; color: #444;">Novartis ended development of iscalimab due to concerns about its benefits versus risks. This decision impacts Sjögren's syndrome patients who were potential candidates for this treatment.</p><span style="color: rgb(4,14,79); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a><a href="https://www.labpulse.com/compliance-regulation/policy-and-regulation/regulatory-approval/article/15736744/alivedx-gets-ce-mark-for-multiplex-autoimmune-test?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="text-decoration: none; color: inherit; display: block;" target="_blank"><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgba(4,14,79,0.03); border-left: 4px solid rgb(4,14,79); transition: background 0.2s ease;"><h3 style="color: rgb(4,14,79); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">AliveDx Receives CE Mark for Autoimmune Test</h3><p style="margin: 0; line-height: 1.6; color: #444;">New diagnostic tools can help identify autoantibodies associated with Sjögren's Syndrome, streamlining diagnosis and treatment by providing more comprehensive results from a single blood sample.</p><span style="color: rgb(4,14,79); display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;">Read More →</span></div></a></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div><h2 style="color: rgb(4,14,79); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; text-align: justify">Latest Research</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div></div><div><div style="margin-bottom: 0px 20px 20px 20px; padding: 20px;"><p style="margin: 0; line-height: 1.6; color: #444; text-align: justify">In a study by <a href="https://onlinelibrary.wiley.com/doi/10.1002/jcu.23926?af=R&sid=researcher&utm_source=researcher_app&utm_medium=referral&utm_campaign=RESR_MRKT_Researcher_inbound&sid=researcher" rel="noopener noreferrer" style="color: rgb(4, 14, 79); text-decoration: none;" target="_blank"><strong>Zhong et al. (2025)</strong></a>, lacrimal gland ultrasonography (LGUS) and shear wave elastography (SWE) were evaluated as diagnostic tools for primary Sjögren's syndrome (PSS). The study included 35 PSS patients and 23 healthy controls. LGUS was used to assess the structure of the lacrimal gland, while SWE measured gland elasticity. The findings showed that LGUS, Emean (elasticity mean), and shear wave velocity (SWV) were significantly higher in PSS patients compared to controls. The optimal LGUS cut-off for diagnosing PSS was a score of 2, with an 80% sensitivity and 69.6% specificity. <br/><br/>For SWE, the best thresholds for PSS diagnosis were 9.4 kPa with a sensitivity of 65.7% and specificity of 82.6%, and 1.7 m/s with a sensitivity of 71.4% and specificity of 91.3%. These tools not only distinguished PSS patients from healthy individuals but also correlated with disease activity and prognosis, as indicated by the european league against rheumatism sjögren's syndrome disease activity index (ESSDAI), hypergammaglobulinemia, and hypocomplementemia. Thus, LGUS and SWE could guide clinical management of PSS.</p></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div><h2 style="color: rgb(4,14,79); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Community News</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div></div><div><a href="https://www.facebook.com/1024838096347853/posts/1022827029882293?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: #ffffff; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(4,14,79); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Feb 03, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">According to our 2021 Living With Sjögren's Patient Survey, 60% percent of respondnts are either no longer working or are working a reduced schedule due to their Sjögren’s, and 29% percent of respondents have changed careers because of their Sjögren’s.</p><div style="width: 100%; margin: 20px 0; border-radius: 5px;"><img alt="Sjögren's Foundation Post" src="https://healthspotlight-newsletters.s3.amazonaws.com/post_images/6067e0be-a2bd-4309-867e-a0cab7759354-20250206-1" style="width: 100%; height: auto; display: block;"/></div></div></a><div style="text-align: center; margin: 0 auto 30px auto;"><div style="display: inline-block; width: 60px; height: 1px; background: rgba(4,14,79,0.3);"></div></div><a href="https://www.facebook.com/1024838096347853/posts/1019955773502752?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" rel="noopener noreferrer" style="text-decoration: none; color: inherit;" target="_blank"><div style="position: relative; margin-bottom: 30px; padding: 20px 20px 15px 20px; border-radius: 8px; background-color: #ffffff; border: 1px solid #ddd; box-shadow: 2px 2px 5px rgba(0,0,0,0.05);"><table style="width: 100%; margin-bottom: 15px;"><tr><td style="width: 50px;"><img alt="Sjögren's Foundation" src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/page_icons/146139558757483.png" style="width:50px; height:50px; border-radius:50%; border: 1px solid #ccc;"/></td><td style="padding-left: 10px;"><strong style="color: rgb(4,14,79); font-size:18px; display: block;">Sjögren's Foundation</strong><span style="color: #999; font-size: 14px; display: block;">Jan 30, 2025</span></td><td style="width: 20px; text-align: right; vertical-align: top;"><img src="https://healthspotlight-newsletters.s3.us-east-1.amazonaws.com/assets/facebook.png" style="width: 20px; height: auto;"/></td></tr></table><p style="color: #333; margin: 0 0 10px 0;">An estimated 93% of Sjögren's patients experience dry mouth, making it one of the most common symptoms of Sjögren's Disease. Many patients will require prescription medications to help treat it but here are some at home solutions that may help alleviate dry mouth.<br/><br/>For more resources and tips, click the link below:<br/><br/><strong style="color: rgb(4,14,79);">https://buff.ly/48xSx1F</strong></p><div style="width: 100%; margin: 20px 0; border-radius: 5px;"><img alt="Sjögren's Foundation Post" src="https://healthspotlight-newsletters.s3.amazonaws.com/post_images/6067e0be-a2bd-4309-867e-a0cab7759354-20250206-2" style="width: 100%; height: auto; display: block;"/></div></div></a></div></td></tr></table></div></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=f79693e2-3309-477a-a05b-bf48c96a9f01&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Sjögren&#39;s Syndrome Insights</title>
  <description>Air Pollution Linked to Higher Risk of Autoimmune Diseases</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/sj-gren-s-syndrome-insights</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/sj-gren-s-syndrome-insights</guid>
  <pubDate>Thu, 23 Jan 2025 18:00:00 +0000</pubDate>
  <atom:published>2025-01-23T18:00:00Z</atom:published>
    <dc:creator>Liam Ball</dc:creator>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><div class="custom_html"><table style="width: 100%; background-color: white; overflow: hidden;"><tbody><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 30px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div><h2 style="color: rgb(4,14,79); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold;">Top Stories</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div></div><div><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgba(4,14,79,0.03); border-left: 4px solid rgb(4,14,79);"><h3 style="color: rgb(4,14,79); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Air Pollution Linked to Higher Risk of Autoimmune Diseases</h3><p style="margin: 0; line-height: 1.6; color: #444;">Exposure to nitrogen oxides and particulate matter may increase the risk of developing autoimmune diseases, including sjögren's syndrome. This suggests that environmental factors could play a role in the onset of these conditions.</p><a href="https://www.healio.com/news/rheumatology/20250122/exposure-to-nitrogen-oxides-particulate-matter-increase-risk-for-autoimmune-disease?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" style="color: rgb(4,14,79); text-decoration: none; display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;" rel="noopener noreferrer">Read More →</a></div><div><div style="margin-bottom: 20px; padding: 20px; border-radius: 8px; background: rgba(4,14,79,0.03); border-left: 4px solid rgb(4,14,79);"><h3 style="color: rgb(4,14,79); margin: 0 0 10px 0; font-size: 18px; font-weight: bold;">Innovative Saliva Test Enhances Sjögrens Diagnosis with Accurate, Community-Centred Approach</h3><p style="margin: 0; line-height: 1.6; color: #444;">The innovative saliva-based model for diagnosing Sjögrens points towards a significant shift in patient care, promising relief from invasive biopsies. By identifying upregulated proteins in saliva, it offers high accuracy.</p><a href="https://www.healio.com/news/rheumatology/20250113/noninvasive-salivabased-sjgrens-diagnosis-model-shows-good-performance?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" style="color: rgb(4,14,79); text-decoration: none; display: inline-block; margin-top: 10px; font-size: 14px; font-weight: bold;" rel="noopener noreferrer">Read More →</a></div></div></div></td></tr><tr><td style="padding: 15px 0px;"><div style="text-align: center; margin-bottom: 10px;"><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div><h2 style="color: rgb(4,14,79); margin: 0 15px; display: inline-block; font-size: 26px; font-weight: bold; text-align: justify">Latest Research</h2><div style="display: inline-block; width: 40px; height: 1px; background: rgba(4,14,79,0.3); vertical-align: middle;"></div></div><div><div style="margin-bottom: 0px 20px 20px 20px; padding: 20px;"><p style="margin: 0; line-height: 1.6; color: #444; text-align: justify">Recent studies have provided new insights into the causes and treatment of Sjögren's syndrome (SS). <a href="https://pubmed.ncbi.nlm.nih.gov/39828845/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" style="color: rgb(4, 14, 79);" rel="noopener noreferrer"><strong>Naeem et al. (2025)</strong></a> described a series of cases that showed how SS can present in unusual ways, highlighting the condition’s wide-ranging symptoms and the importance of early diagnosis through greater awareness. <br><br>Similarly, <a href="https://pubmed.ncbi.nlm.nih.gov/39819714/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" style="color: rgb(4, 14, 79);" rel="noopener noreferrer"><strong>Zhang et al. (2025)</strong></a> explored how miR-155-5p plays a role in primary SS. Their research showed that blocking this molecule helps human submandibular gland cells grow by improving activity in the PI3K/AKT pathway via PIK3R1, pointing to potential new treatments for gland dysfunction in SS. <br><br>Finally, <a href="https://link.springer.com/article/10.1186/s12967-024-05993-z?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" style="color: rgb(4, 14, 79);" rel="noopener noreferrer"><strong>Xu et al. (2025)</strong></a> carried out a detailed analysis of immune cell types and inflammation markers in SS. Their findings could help tailor treatments based on genetic factors, offering new hope for improved care and outcomes.</p></div></div></td></tr></tbody></table></div></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=9c297077-f890-49d0-a772-a5119c447eee&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Weekly Spotlight - 09.01.25</title>
  <description>Scientists Uncover Key Mechanisms Behind Autoimmune Disorder in Patients</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/weekly-spotlight-09-01-25</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/weekly-spotlight-09-01-25</guid>
  <pubDate>Thu, 09 Jan 2025 18:00:00 +0000</pubDate>
  <atom:published>2025-01-09T18:00:00Z</atom:published>
    <dc:creator>Liam Ball</dc:creator>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><p class="paragraph" style="text-align:center;"><a class="link" href="https://sjogrens-syndrome.healthspotlight.io/subscribe?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Subscribe</a> | Follow us on <b><a class="link" href="https://www.linkedin.com/showcase/sjogrens-syndrome-insights/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">LinkedIn</a></b> 🔗</p><p class="paragraph" style="text-align:left;"></p><div class="section" style="background-color:#f8f8f8;border-color:#222222;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><div style="padding:14px 15px 14px;"><table class="bh__table" width="100%" style="border-collapse:collapse;"><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(3, 153, 205);font-family:"Aptos Narrow", sans-serif;font-size:18pt;"><b>Community</b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://forms.office.com/e/kEtaEqnVKA?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Share Your Story, Inspire Hope</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;">Your journey can be a beacon of hope and a source of strength for others in our community. Together, we can build a stronger, more supportive community. Your story matters, and it deserves to be heard. Fill in this <b><a class="link" href="https://forms.office.com/pages/responsepage.aspx?id=vUNT3cTym0-BeI37ZEWRG8EB4W-Y4JVJi5xFnmMx2iRUNURaVzZBS1NPMUFBVkw2VlE4RFJDODVPUS4u&route=shorturl&utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">form</a></b> to be featured.</p></td></tr></table></div></div><div class="section" style="background-color:#f8f8f8;border-color:#222222;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><div style="padding:14px 15px 14px;"><table class="bh__table" width="100%" style="border-collapse:collapse;"><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(5, 153, 205);font-family:"Aptos Narrow", sans-serif;font-size:18pt;"><b>Latest News</b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(60, 128, 245);font-family:"Aptos Display", sans-serif;"><b><a class="link" href="https://sjogrenssyndromenews.com/news/researchers-reveal-mechanisms-underlying-sjogrens-disease/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Scientists Uncover Key Mechanisms Behind Autoimmune Disorder in Patients</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="font-family:"Aptos Narrow", sans-serif;font-size:12pt;">Researchers have uncovered new mechanisms behind Sjogren&#39;s syndrome, including how immune cells and genetic factors contribute to the disease. The study sheds light on the complex interactions that lead to the symptoms and complications of Sjogren&#39;s syndrome, potentially paving the way for better treatments.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(60, 128, 245);font-family:"Aptos Display", sans-serif;"><b><a class="link" href="https://www.medscape.com/viewarticle/sj%C3%B6gren-subtypes-have-distinct-pathophysiologic-2025a100009j?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">New Study Reveals Distinct Pathophysiologic Profiles in Sjögren&#39;s Subtypes</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="font-family:"Aptos Narrow", sans-serif;font-size:12pt;">Researchers have identified distinct subtypes of Sjogren&#39;s syndrome, each with different underlying biological mechanisms. These subtypes can help in understanding the varied symptoms and responses to treatment, potentially leading to more personalized care for patients with Sjogren&#39;s syndrome.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(60, 128, 245);font-family:"Aptos Display", sans-serif;"><b><a class="link" href="http://www.msn.com/en-gb/health/other/dry-mouth-could-be-a-red-flag-of-serious-illnesses-including-diabetes-and-stroke/ar-AA1wQkJg?ocid=bingnewssearch&apiversion=v2&noservercache=1&domshim=1&renderwebcomponents=1&wcseo=1&batchservertelemetry=1&noservertelemetry=1&utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Dry Mouth Could Signal Serious Health Issues Like Sjogren’s and Stroke</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="font-family:"Aptos Narrow", sans-serif;font-size:12pt;">Dry mouth can be a symptom of serious health issues, including diabetes, stroke, and Sjogren&#39;s syndrome. It is important to consult a doctor if you experience persistent dry mouth to rule out underlying conditions. Early diagnosis and treatment can significantly improve health outcomes.</span></p></td></tr></table></div></div><div class="image"><img alt="" class="image__image" style="border-radius:0px 0px 0px 0px;border-style:solid;border-width:0px 0px 0px 0px;box-sizing:border-box;border-color:#E5E7EB;" src="https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/9b6578ae-a61b-40f5-998f-8b9a29feccf5/Icon_Blue.png?t=1726247509"/></div><p class="paragraph" style="text-align:center;"><span style="font-size:0.6rem;">Health Spotlight’s Sjögren’s Syndrome is a </span><span style="font-size:0.6rem;"><a class="link" href="https://www.contentive.com/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Contentive</a></span><span style="font-size:0.6rem;"> publication in the </span><span style="color:rgb(99, 32, 238);font-size:0.6rem;">Healthcare</span><span style="font-size:0.6rem;"> division</span></p></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=22517188-1a99-4bac-b501-59e36dae7ebb&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Weekly Spotlight - 19.12.24</title>
  <description>Neuropathic Pain and Urinary Symptoms Linked to Primary Sjögren&#39;s Syndrome</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/weekly-spotlight-19-12-24</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/weekly-spotlight-19-12-24</guid>
  <pubDate>Thu, 19 Dec 2024 18:00:00 +0000</pubDate>
  <atom:published>2024-12-19T18:00:00Z</atom:published>
    <dc:creator>Liam Ball</dc:creator>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><p class="paragraph" style="text-align:center;"><a class="link" href="https://sjogrens-syndrome.healthspotlight.io/subscribe?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Subscribe</a> | Follow us on <b><a class="link" href="https://www.linkedin.com/showcase/sjogrens-syndrome-insights/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">LinkedIn</a></b> 🔗</p><p class="paragraph" style="text-align:left;"></p><div class="section" style="background-color:#f8f8f8;border-color:#222222;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><div style="padding:14px 15px 14px;"><table class="bh__table" width="100%" style="border-collapse:collapse;"><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(3, 153, 205);font-family:"Aptos Narrow", sans-serif;font-size:18pt;"><b>Community</b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://forms.office.com/e/kEtaEqnVKA?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Share Your Story, Inspire Hope</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;">Your journey can be a beacon of hope and a source of strength for others in our community. Together, we can build a stronger, more supportive community. Your story matters, and it deserves to be heard. Fill in this <b><a class="link" href="https://forms.office.com/pages/responsepage.aspx?id=vUNT3cTym0-BeI37ZEWRG8EB4W-Y4JVJi5xFnmMx2iRUNURaVzZBS1NPMUFBVkw2VlE4RFJDODVPUS4u&route=shorturl&utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">form</a></b> to be featured.</p></td></tr></table></div></div><div class="section" style="background-color:#f8f8f8;border-color:#222222;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><div style="padding:14px 15px 14px;"><table class="bh__table" width="100%" style="border-collapse:collapse;"><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(5, 153, 205);font-family:"Aptos Narrow", sans-serif;font-size:18pt;"><b>Latest News</b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(60, 128, 245);font-family:"Aptos Display", sans-serif;"><b><a class="link" href="https://sjogrenssyndromenews.com/news/neuropathic-pain-urinary-symptoms-seen-tied-primary-sjogrens/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Neuropathic Pain and Urinary Symptoms Linked to Primary Sjogren&#39;s Syndrome</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="font-family:"Aptos Narrow", sans-serif;font-size:12pt;">Research shows that people with primary Sjögren&#39;s syndrome are more likely to experience neuropathic pain and urinary symptoms. These symptoms can significantly impact quality of life and highlight the need for comprehensive care to manage the full spectrum of the disease.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(60, 128, 245);font-family:"Aptos Display", sans-serif;"><b><a class="link" href="https://www.healio.com/news/rheumatology/20241212/potential-sjgrens-drugs-may-herald-paradigm-shift-to-treating-underlying-processes?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">New Drugs Target Underlying Processes in Autoimmune Disorders, Offering Hope for Patients</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="font-family:"Aptos Narrow", sans-serif;font-size:12pt;">New drugs being developed for Sjögren&#39;s syndrome may mark a significant change in treatment by targeting the underlying immune system processes rather than just managing symptoms, offering potential for more effective and lasting relief. These medications aim to address the root causes of the disease.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(60, 128, 245);font-family:"Aptos Display", sans-serif;"><b><a class="link" href="https://medicalxpress.com/news/2024-12-reveal-mechanisms-underlying-sjgren-disease.html?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">New Study Reveals Mechanisms Behind Autoimmune Disorder in Patients</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="font-family:"Aptos Narrow", sans-serif;font-size:12pt;">New research reveals the underlying mechanisms of Sjögren&#39;s disease, highlighting how immune cells and genetic factors contribute to the condition. The study provides insights into the disease&#39;s progression and potential targets for future treatments, offering hope for improved management and therapy for those affected by Sjögren&#39;s.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(60, 128, 245);font-family:"Aptos Display", sans-serif;"><b><a class="link" href="https://www.cureus.com/articles/325673-fibrillary-glomerulonephritis-in-a-patient-with-sjgrens-syndrome-and-primary-biliary-cholangitis-a-case-report-and-literature-review?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Rare Kidney Condition in Patient with Autoimmune Disorders: Case Report and Review</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="font-family:"Aptos Narrow", sans-serif;font-size:12pt;">A patient with Sjögren&#39;s syndrome and primary biliary cholangitis developed a rare kidney condition called fibrillary glomerulonephritis. The case report and literature review discuss the diagnosis, treatment, and potential connections between these conditions, highlighting the importance of monitoring kidney health in patients with autoimmune diseases.</span></p></td></tr></table></div></div><div class="image"><img alt="" class="image__image" style="border-radius:0px 0px 0px 0px;border-style:solid;border-width:0px 0px 0px 0px;box-sizing:border-box;border-color:#E5E7EB;" src="https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/9b6578ae-a61b-40f5-998f-8b9a29feccf5/Icon_Blue.png?t=1726247509"/></div><p class="paragraph" style="text-align:center;"><span style="font-size:0.6rem;">Health Spotlight’s Sjögren’s Syndrome is a </span><span style="font-size:0.6rem;"><a class="link" href="https://www.contentive.com/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Contentive</a></span><span style="font-size:0.6rem;"> publication in the </span><span style="color:rgb(99, 32, 238);font-size:0.6rem;">Healthcare</span><span style="font-size:0.6rem;"> division</span></p></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=d0c0d527-1ff1-4c68-9dd4-a0e1b5efa659&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Weekly Spotlight - 12.12.24</title>
  <description>Rare Pleural Effusion in Young Woman Reveals Sjogren Syndrome Insight</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/weekly-spotlight-12-12-24</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/weekly-spotlight-12-12-24</guid>
  <pubDate>Thu, 12 Dec 2024 18:00:00 +0000</pubDate>
  <atom:published>2024-12-12T18:00:00Z</atom:published>
    <dc:creator>Liam Ball</dc:creator>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><p class="paragraph" style="text-align:center;"><a class="link" href="https://sjogrens-syndrome.healthspotlight.io/subscribe?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Subscribe</a> | Follow us on <b><a class="link" href="https://www.linkedin.com/showcase/sjogrens-syndrome-insights/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">LinkedIn</a></b> 🔗</p><p class="paragraph" style="text-align:left;"></p><div class="section" style="background-color:#f8f8f8;border-color:#222222;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><div style="padding:14px 15px 14px;"><table class="bh__table" width="100%" style="border-collapse:collapse;"><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(3, 153, 205);font-family:"Aptos Narrow", sans-serif;font-size:18pt;"><b>Community</b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://forms.office.com/e/kEtaEqnVKA?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Share Your Story, Inspire Hope</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;">Your journey can be a beacon of hope and a source of strength for others in our community. Together, we can build a stronger, more supportive community. Your story matters, and it deserves to be heard. Fill in this <b><a class="link" href="https://forms.office.com/pages/responsepage.aspx?id=vUNT3cTym0-BeI37ZEWRG8EB4W-Y4JVJi5xFnmMx2iRUNURaVzZBS1NPMUFBVkw2VlE4RFJDODVPUS4u&route=shorturl&utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">form</a></b> to be featured.</p></td></tr></table></div></div><div class="section" style="background-color:transparent;border-color:black;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><h2 class="heading" style="text-align:center;"><b>Latest News</b></h2><h3 class="heading" style="text-align:left;"><span style="color:rgb(61, 128, 245);font-family:Roboto, -apple-system, BlinkMacSystemFont, Tahoma, sans-serif;font-size:16px;"><b><a class="link" href="https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.cureus.com%2Farticles%2F318711-primary-sjogrens-syndrome-presenting-as-pleuritis-and-pleural-effusion%23%21%2F&data=05%7C02%7Cseb.may%40delfy.ai%7C8c3773b2b7604ab7315508dd1a032389%7Cdd5343bdf2c44f9b81788dfb6445911b%7C0%7C0%7C638695322969319632%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=063b7huTe2mFb%2B53ocPUxB37yQ6Pj58acIgTCRcxbpM%3D&reserved=0&utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow" style="color: rgb(61, 128, 245)">Rare Pleural Effusion in Young Woman Reveals Sjogren Syndrome Insight</a></b></span></h3><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:"Aptos Narrow", sans-serif;font-size:16px;">The article discusses a rare case of Primary Sjogren Syndrome presenting as pleuritis and pleural effusion. A young woman experienced unexplained pleural effusion, leading to a diagnosis of Sjogren after thorough testing. This highlights the importance of considering autoimmune causes in similar cases for effective treatment.</span></p><h3 class="heading" style="text-align:left;"><span style="color:rgb(61, 128, 245);font-family:Roboto, -apple-system, BlinkMacSystemFont, Tahoma, sans-serif;font-size:16px;"><b><a class="link" href="https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fsjogrenssyndromenews.com%2Fnews%2Fainos-taiwan-tanabe-manufacture-low-dose-interferon-alpha-sjogrens%2F&data=05%7C02%7Cseb.may%40delfy.ai%7C8c3773b2b7604ab7315508dd1a032389%7Cdd5343bdf2c44f9b81788dfb6445911b%7C0%7C0%7C638695322969355907%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=uPgBkrWgkdaNyy%2BaJ%2BoxYxFX97KGBtSmSs902J3BPjA%3D&reserved=0&utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow" style="color: rgb(61, 128, 245)">Ainos and Taiwan Tanabe Partner to Enhance Sjögren Treatment Availability</a></b></span></h3><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:"Aptos Narrow", sans-serif;font-size:16px;">Ainos and Taiwan Tanabe Seiyaku are collaborating to produce low-dose interferon alpha for Sjögren disease in Taiwan. This partnership aims to enhance global access to the treatment, which has shown promise in improving saliva production and reducing dryness in clinical trials, offering hope to patients worldwide.</span></p><h3 class="heading" style="text-align:left;"><span style="color:rgb(61, 128, 245);font-family:Roboto, -apple-system, BlinkMacSystemFont, Tahoma, sans-serif;font-size:16px;"><b><a class="link" href="https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fin-cyprus.philenews.com%2Finternational%2Fstudy-links-untreated-infertility-to-higher-autoimmune-disease-risk-in-women%2F&data=05%7C02%7Cseb.may%40delfy.ai%7C8c3773b2b7604ab7315508dd1a032389%7Cdd5343bdf2c44f9b81788dfb6445911b%7C0%7C0%7C638695322969371787%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=Y8M54Xs1ijAIpvnKtPheA46CbKzd5fvctm0j1t3lS7Y%3D&reserved=0&utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow" style="color: rgb(61, 128, 245)">Untreated Infertility Raises Autoimmune Disease Risk, Study Reveals</a></b></span></h3><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:"Aptos Narrow", sans-serif;font-size:16px;">New research from the University of Toronto reveals that women with untreated infertility face a 25% higher risk of developing systemic autoimmune rheumatic diseases (SARDs). The study suggests infertility care could allow early screening for rheumatic symptoms, offering hope for timely intervention and improved health outcomes.</span></p></div><div class="image"><img alt="" class="image__image" style="border-radius:0px 0px 0px 0px;border-style:solid;border-width:0px 0px 0px 0px;box-sizing:border-box;border-color:#E5E7EB;" src="https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/9b6578ae-a61b-40f5-998f-8b9a29feccf5/Icon_Blue.png?t=1726247509"/></div><p class="paragraph" style="text-align:center;"><span style="font-size:0.6rem;">Health Spotlight’s Sjögren’s Syndrome is a </span><span style="font-size:0.6rem;"><a class="link" href="https://www.contentive.com/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Contentive</a></span><span style="font-size:0.6rem;"> publication in the </span><span style="color:rgb(99, 32, 238);font-size:0.6rem;">Healthcare</span><span style="font-size:0.6rem;"> division</span></p></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=39d6c041-5f3a-486f-bdce-79a5f2e509d0&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Weekly Spotlight - 21.11.24</title>
  <description>Genetic links, overlap syndrome, and therapeutic advances in Sjögren’s syndrome.</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/weekly-spotlight-21-11-24</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/weekly-spotlight-21-11-24</guid>
  <pubDate>Thu, 21 Nov 2024 18:00:00 +0000</pubDate>
  <atom:published>2024-11-21T18:00:00Z</atom:published>
    <dc:creator>Liam Ball</dc:creator>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><p class="paragraph" style="text-align:center;"><a class="link" href="https://sjogrens-syndrome.healthspotlight.io/subscribe?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Subscribe</a> | <a class="link" href="{{rp_referral_hub_url}}" target="_blank" rel="noopener noreferrer nofollow">Share with your community</a></p><div class="section" style="background-color:#f8f8f8;border-color:#222222;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><div style="padding:14px 15px 14px;"><table class="bh__table" width="100%" style="border-collapse:collapse;"><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(3, 153, 205);font-family:Aptos Narrow, sans-serif;font-size:18pt;"><b>Community</b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://forms.office.com/e/kEtaEqnVKA?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">We want to hear your story!</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!</span></p></td></tr></table></div></div><p class="paragraph" style="text-align:left;"></p><div class="section" style="background-color:#f8f8f8;border-color:#222222;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><div style="padding:14px 15px 14px;"><table class="bh__table" width="100%" style="border-collapse:collapse;"><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(5, 153, 205);font-family:Aptos Narrow, sans-serif;font-size:18pt;"><b>Latest News</b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(60, 128, 245);font-family:Aptos Display, sans-serif;"><b><a class="link" href="https://www.pharmacytimes.com/view/fda-grants-breakthrough-therapy-designation-for-nipocalimab-for-sj-gren-disease?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">FDA Designates Nipocalimab as Breakthrough Therapy for Sjogren&#39;s Disease</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="font-family:Aptos Narrow, sans-serif;font-size:12pt;">The FDA has given nipocalimab a breakthrough therapy designation for treating Sjogren&#39;s disease, indicating it shows significant improvement over existing treatments. This designation speeds up the development and review process, potentially bringing this new therapy to patients faster. Nipocalimab targets specific immune cells involved in the disease.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(60, 128, 245);font-family:Aptos Display, sans-serif;"><b><a class="link" href="https://www.businesswire.com/news/home/20241118858480/en/Capstan-Therapeutics-Presents-Preclinical-Data-on-Lead-In-Vivo-CAR-T-Candidate-CPTX2309-at-American-College-of-Rheumatology-ACR-Convergence-2024?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Capstan Therapeutics Shares Promising CAR-T Therapy Data for Autoimmune Diseases</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="font-family:Aptos Narrow, sans-serif;font-size:12pt;">Capstan Therapeutics presented preclinical data on CPTX2309, a CAR-T cell therapy, at the American College of Rheumatology Convergence 2024. The study shows potential for treating autoimmune diseases by targeting specific cells, offering hope for new treatment options. This therapy could potentially reduce inflammation and improve symptoms in conditions like Sjogren&#39;s syndrome.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(60, 128, 245);font-family:Aptos Display, sans-serif;"><b><a class="link" href="https://www.stocktitan.net/news/AIMDW/water-tower-research-highlights-irb-approval-for-the-ainos-veldona-0mqapp5vim20.html?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Water Tower Research Gains IRB Approval for Ainos Veldona Study</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="font-family:Aptos Narrow, sans-serif;font-size:12pt;">Water Tower Research has received Institutional Review Board (IRB) approval to conduct a study on Ainos&#39; Veldona, a potential treatment for Sjogren&#39;s syndrome. This approval is a significant step forward in evaluating the safety and efficacy of Veldona, which could offer new hope for patients suffering from this autoimmune disorder.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(60, 128, 245);font-family:Aptos Display, sans-serif;"><b><a class="link" href="https://www.news9live.com/health/health-conditions/the-estrogen-effect-explained-why-women-are-more-prone-to-arthritis-2751094?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Why Women Are More Prone to Sjogren’s Syndrome</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="font-family:Aptos Narrow, sans-serif;font-size:12pt;">Women are more likely to develop arthritis due to the impact of estrogen on the immune system. Estrogen can both protect and exacerbate joint inflammation, making women more susceptible to autoimmune diseases like rheumatoid arthritis. Hormonal changes, especially during menopause, can also play a role in this increased risk.</span></p></td></tr></table></div></div><div class="image"><img alt="" class="image__image" style="border-radius:0px 0px 0px 0px;border-style:solid;border-width:0px 0px 0px 0px;box-sizing:border-box;border-color:#E5E7EB;" src="https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/9b6578ae-a61b-40f5-998f-8b9a29feccf5/Icon_Blue.png?t=1726247509"/></div><p class="paragraph" style="text-align:center;"><span style="font-size:0.6rem;">Health Spotlight’s Sjögren’s Syndrome is a </span><span style="font-size:0.6rem;"><a class="link" href="https://www.contentive.com/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Contentive</a></span><span style="font-size:0.6rem;"> publication in the </span><span style="color:rgb(99, 32, 238);font-size:0.6rem;">Healthcare</span><span style="font-size:0.6rem;"> division</span></p></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=d7d61096-ef52-4119-b740-ef6d32d9b02b&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Weekly Spotlight - 07.11.24</title>
  <description>Genetic links, overlap syndrome, and therapeutic advances in Sjögren’s syndrome.</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/weekly-spotlight-07-11-24</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/weekly-spotlight-07-11-24</guid>
  <pubDate>Thu, 07 Nov 2024 18:00:00 +0000</pubDate>
  <atom:published>2024-11-07T18:00:00Z</atom:published>
    <dc:creator>Liam Ball</dc:creator>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><p class="paragraph" style="text-align:center;"><a class="link" href="https://sjogrens-syndrome.healthspotlight.io/subscribe?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Subscribe</a> | <a class="link" href="{{rp_referral_hub_url}}" target="_blank" rel="noopener noreferrer nofollow">Share with your community</a></p><div class="section" style="background-color:#f8f8f8;border-color:#222222;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><div style="padding:14px 15px 14px;"><table class="bh__table" width="100%" style="border-collapse:collapse;"><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(3, 153, 205);font-family:Aptos Narrow, sans-serif;font-size:18pt;"><b>Community</b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://forms.office.com/e/kEtaEqnVKA?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">We want to hear your story!</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!</span></p></td></tr></table></div></div><p class="paragraph" style="text-align:left;"></p><div class="section" style="background-color:#f8f8f8;border-color:#222222;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><div style="padding:14px 15px 14px;"><table class="bh__table" width="100%" style="border-collapse:collapse;"><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(3, 153, 205);font-family:Aptos Narrow, sans-serif;font-size:18pt;"><b>In the News</b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://www.sciencedirect.com/science/article/pii/S2666602224001253?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Sjogren&#39;s Syndrome Linked to Cardiovascular Risks: A Genetic Study</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">A two-sample Mendelian randomization study indicates a causal link between Sjogren’s syndrome and cardiovascular diseases like ischemic stroke, chronic heart failure, and non-rheumatic valvular heart disease. These findings could shift clinical attention toward preventive cardiovascular care for Sjogren&#39;s patients, although further research is essential to validate these results across different populations.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://www.sciencedirect.com/science/article/pii/S2667257X24000317?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Neuromyelitis Optica with Sjogren&#39;s and Biliary Cholangitis: A Case Study</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">A 30-year-old woman with Neuromyelitis Optica Spectrum Disorder also had Sjogren’s Syndrome and Primary Biliary Cholangitis. Her symptoms improved significantly after treatments like steroids, immunoglobulin, and rituximab. This case underscores the importance of recognizing overlapping autoimmune disorders for timely and effective treatment.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://sjogrenssyndromenews.com/news/aqp5-antibody-possible-diagnostic-biomarker-primary-sjogrens/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">AQP5 Antibody: A New Hope for Sjögren&#39;s Diagnosis</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">A Chinese research team has identified the AQP5 antibody as a promising diagnostic biomarker for primary Sjogren’s disease, showing higher sensitivity than current markers. If validated, AQP5 could significantly enhance diagnostic accuracy, benefiting early treatment and disease management.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://link.springer.com/article/10.1007/s10067-024-07165-2?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Low-Dose IL-2 Therapy&#39;s Metabolic Benefits for Sjögren&#39;s Syndrome</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">Low-dose IL-2 therapy offers promising benefits for primary Sjogren&#39;s Syndrome by improving metabolic and immune functions. Patients experienced positive changes in metabolite levels, enhancing immune cell function and possibly improving quality of life. This approach represents a new therapeutic avenue for autoimmune management, although additional studies are needed.</span></p></td></tr></table></div></div><div class="image"><img alt="" class="image__image" style="border-radius:0px 0px 0px 0px;border-style:solid;border-width:0px 0px 0px 0px;box-sizing:border-box;border-color:#E5E7EB;" src="https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/9b6578ae-a61b-40f5-998f-8b9a29feccf5/Icon_Blue.png?t=1726247509"/></div><p class="paragraph" style="text-align:center;"><span style="font-size:0.6rem;">Health Spotlight’s Sjögren’s Syndrome is a </span><span style="font-size:0.6rem;"><a class="link" href="https://www.contentive.com/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Contentive</a></span><span style="font-size:0.6rem;"> publication in the </span><span style="color:rgb(99, 32, 238);font-size:0.6rem;">Healthcare</span><span style="font-size:0.6rem;"> division</span></p></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=bf0667ac-8d4f-4b41-b3c7-1ebc95bc0d4d&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Weekly Spotlight - 31.10.24</title>
  <description>Innovative treatments, personal journeys, and important research breakthroughs related to autoimmune disorders.</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/weekly-spotlight-31-10-24</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/weekly-spotlight-31-10-24</guid>
  <pubDate>Thu, 31 Oct 2024 18:00:00 +0000</pubDate>
  <atom:published>2024-10-31T18:00:00Z</atom:published>
    <dc:creator>Liam Ball</dc:creator>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><p class="paragraph" style="text-align:center;"><a class="link" href="https://sjogrens-syndrome.healthspotlight.io/subscribe?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Subscribe</a> | <a class="link" href="{{rp_referral_hub_url}}" target="_blank" rel="noopener noreferrer nofollow">Share with your community</a></p><div class="section" style="background-color:#f8f8f8;border-color:#222222;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><div style="padding:14px 15px 14px;"><table class="bh__table" width="100%" style="border-collapse:collapse;"><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(3, 153, 205);font-family:Aptos Narrow, sans-serif;font-size:18pt;"><b>Community</b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://forms.office.com/e/kEtaEqnVKA?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">We want to hear your story!</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!</span></p></td></tr></table></div></div><div class="section" style="background-color:#f8f8f8;border-color:#222222;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><div style="padding:14px 15px 14px;"><table class="bh__table" width="100%" style="border-collapse:collapse;"><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(3, 153, 205);font-family:Aptos Narrow, sans-serif;font-size:18pt;"><b>In the News</b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://www.sciencedirect.com/science/article/pii/S1081120624011128?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Innovative Treatment Brings Hope to Autoimmune Angioedema Patients</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">A 66-year-old woman with autoimmune disease experienced severe angioedema, unresponsive to standard treatments. Therapeutic plasma exchange (TPE) was used, leading to remission. This case underscores the potential of TPE in managing refractory angioedema linked to autoimmunity, offering hope for similar patients.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://sjogrenssyndromenews.com/news/blood-ttr-primary-sjogrens-disease-activity-biomarker-study/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Blood TTR: A New Hope for Sjögren&#39;s Disease Management</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">Blood levels of transthyretin (TTR) may serve as a biomarker for primary Sjögren&#39;s disease activity, according to a Chinese study. TTR, linked to autoimmune diseases, correlates with disease activity and inflammation markers, offering potential for improved clinical management of Sjögren&#39;s patients.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://www.thewrap.com/solange-knowles-pots-sjogrens-mcas-health-update-diagnosis/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Solange Knowles Shares Her Autoimmune Disorder Journey with Fans</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">Solange Knowles has shared her diagnosis of POTS, Sjögren&#39;s syndrome, and MCAS, highlighting the challenges of living with these conditions. She expressed gratitude for the support from Dysautonomia International and the &quot;spoonie&quot; community, offering encouragement to others facing similar health struggles.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://www.sciencedirect.com/science/article/pii/S1081120624011037?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Abdominal Pain Unveils Rare C1 Inhibitor Deficiency Diagnosis</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">A 62-year-old woman experienced severe abdominal pain, leading to a diagnosis of acquired C1 esterase inhibitor deficiency, a rare condition linked to lymphoproliferative disorders. Despite initial treatment challenges, she received supportive care, highlighting the importance of considering this diagnosis in similar cases for effective management.</span></p></td></tr></table></div></div><div class="image"><img alt="" class="image__image" style="border-radius:0px 0px 0px 0px;border-style:solid;border-width:0px 0px 0px 0px;box-sizing:border-box;border-color:#E5E7EB;" src="https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/9b6578ae-a61b-40f5-998f-8b9a29feccf5/Icon_Blue.png?t=1726247509"/></div><p class="paragraph" style="text-align:center;"><span style="font-size:0.6rem;">Health Spotlight’s Sjögren’s Syndrome is a </span><span style="font-size:0.6rem;"><a class="link" href="https://www.contentive.com/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Contentive</a></span><span style="font-size:0.6rem;"> publication in the </span><span style="color:rgb(99, 32, 238);font-size:0.6rem;">Healthcare</span><span style="font-size:0.6rem;"> division</span></p></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=d2086b37-e675-482f-8a46-dbcd0f23454c&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

      <item>
  <title>Weekly Spotlight - 24.10.24</title>
  <description>Latest insights covering recent research on adverse reactions to Belimumab, genetic links to Sjogren&#39;s syndrome, and the potential clinical implications of adropin.</description>
  <link>https://sjogrens-syndrome.beehiiv.com/p/weekly-spotlight-24-10-24</link>
  <guid isPermaLink="true">https://sjogrens-syndrome.beehiiv.com/p/weekly-spotlight-24-10-24</guid>
  <pubDate>Thu, 24 Oct 2024 17:00:00 +0000</pubDate>
  <atom:published>2024-10-24T17:00:00Z</atom:published>
    <dc:creator>Liam Ball</dc:creator>
  <content:encoded><![CDATA[
    <div class='beehiiv'><style>
  .bh__table, .bh__table_header, .bh__table_cell { border: 0px solid #e5ddff; }
  .bh__table_cell { padding: 5px; background-color: #f8f8f8; }
  .bh__table_cell p { color: #2D2D2D; font-family: 'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
  .bh__table_header { padding: 5px; background-color:#f8f8f8; }
  .bh__table_header p { color: #011053; font-family:'Roboto',-apple-system,BlinkMacSystemFont,Tahoma,sans-serif !important; overflow-wrap: break-word; }
</style><div class='beehiiv__body'><p class="paragraph" style="text-align:center;"><a class="link" href="https://sjogrens-syndrome.healthspotlight.io/subscribe?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Subscribe</a> | <a class="link" href="{{rp_referral_hub_url}}" target="_blank" rel="noopener noreferrer nofollow">Share with your community</a></p><div class="section" style="background-color:#f8f8f8;border-color:#222222;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><div style="padding:14px 15px 14px;"><table class="bh__table" width="100%" style="border-collapse:collapse;"><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(3, 153, 205);font-family:Aptos Narrow, sans-serif;font-size:18pt;"><b>In the News</b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://onlinelibrary.wiley.com/doi/abs/10.1002/pds.70037?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Belimumab&#39;s Real-World Adverse Reactions: A Comprehensive Study</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">The study examines adverse reactions to Belimumab using the FDA&#39;s database, highlighting the need for careful monitoring. It found 19,825 reports, mostly from the US, with women predominantly affected. Key adverse reactions include hypersensitivity and immunosuppression. The research underscores the importance of vigilant clinical monitoring for safe medication use.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://www.researchsquare.com/article/rs-5006632/v1?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Genetic Links Between Viral Infections and Sjogren&#39;s Syndrome Uncovered</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">The study explores the genetic links between viral infections and Sjogren&#39;s syndrome, revealing that elevated antibodies against EBV, HAV, and COVID-19 increase SS risk, while IgG antibodies against EBV and HIV may offer protection. This research aids clinicians in identifying potential causative factors, enhancing diagnostic accuracy and treatment strategies.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://www.benthamdirect.com/content/journals/cp/10.2174/0115701646301720240830070246?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Adropin&#39;s Role in Disease Diagnosis and Treatment Potential</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">Adropin, a 76-amino acid protein, plays a crucial role in energy balance and endothelial protection. Its levels vary in conditions like obesity, diabetes, and heart disease. This review highlights adropin&#39;s potential in diagnosing and treating diseases, offering hope for managing diabetes, atherosclerosis, and cognitive decline-related disorders.</span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://www.lupusresearch.org/congratulations-to-dr-lindsey-criswell-for-election-to-national-academy-of-medicine/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Dr. Lindsey Criswell Honoured by National Academy of Medicine for Contributions</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">Dr. Lindsey Criswell, Director of NIAMS, has been elected to the National Academy of Medicine. Her pioneering research on genetic and epigenetic factors in autoimmune disorders has significantly advanced understanding of diseases like lupus and rheumatoid arthritis. This prestigious honour recognises her outstanding contributions to health and medicine.</span></p></td></tr></table></div></div><p class="paragraph" style="text-align:left;"></p><div class="section" style="background-color:#f8f8f8;border-color:#222222;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><div style="padding:14px 15px 14px;"><table class="bh__table" width="100%" style="border-collapse:collapse;"><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(3, 153, 205);font-family:Aptos Narrow, sans-serif;font-size:18pt;"><b>Digital Innovation in the NHS</b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:rgb(61, 128, 245);"><b><a class="link" href="https://www.theguardian.com/society/2024/oct/21/wes-streeting-unveils-plans-for-patient-passports-to-hold-all-medical-records?utm_source=als.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Digital Patient Passports to Revolutionise NHS Healthcare</a></b></span></p></td></tr><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:left;"><span style="color:black;font-family:Aptos Narrow, sans-serif;">Wes Streeting, the health secretary, has unveiled an ambitious plan to r</span><span style="color:black;font-family:Aptos Narrow, sans-serif;"><b>evolutionise healthcare in the UK by introducing patient passports</b></span><span style="color:black;font-family:Aptos Narrow, sans-serif;">, which will digitally store all NHS medical records in one accessible location. This transformative initiative aims to enhance patient care by allowing </span><span style="color:black;font-family:Aptos Narrow, sans-serif;"><b>swift access to health data for GPs, hospitals, and ambulance services</b></span><span style="color:black;font-family:Aptos Narrow, sans-serif;">, thereby reducing repeat tests and medication errors. The digital data bill will standardise information systems across the NHS, creating a </span><span style="color:black;font-family:Aptos Narrow, sans-serif;"><b>unified patient record on the NHS app</b></span><span style="color:black;font-family:Aptos Narrow, sans-serif;">. </span><br><br><span style="color:black;font-family:Aptos Narrow, sans-serif;">Despite the potential benefits,</span><span style="color:black;font-family:Aptos Narrow, sans-serif;"><b> concerns about privacy and data security have been raised</b></span><span style="color:black;font-family:Aptos Narrow, sans-serif;">. Critics, including </span><span style="color:black;font-family:Aptos Narrow, sans-serif;"><b>medConfidential</b></span><span style="color:black;font-family:Aptos Narrow, sans-serif;">, warn that the centralised database could become a target for hackers and misuse by unauthorised personnel. Public scepticism is evident, with a significant portion of the population expressing distrust in the NHS&#39;s ability to keep data secure. </span><br><br><span style="color:black;font-family:Aptos Narrow, sans-serif;">Streeting, however, remains optimistic, emphasising the collaboration with tech and pharma companies to develop new treatments and ensure the NHS benefits from cutting-edge advancements. </span><span style="color:black;font-family:Aptos Narrow, sans-serif;"><b>He assures that patient data will be protected and anonymised</b></span><span style="color:black;font-family:Aptos Narrow, sans-serif;">, addressing fears of &quot;big brother&quot; oversight. The government is also focusing on shifting healthcare from hospitals to community-based centres and prioritising prevention over treatment, with plans to distribute wearable tech for health monitoring. </span><br><br><span style="color:black;font-family:Aptos Narrow, sans-serif;">This bold vision for the NHS seeks to </span><span style="color:black;font-family:Aptos Narrow, sans-serif;"><b>harness the power of digital innovation to improve healthcare delivery</b></span><span style="color:black;font-family:Aptos Narrow, sans-serif;">, but it must navigate the delicate balance between technological advancement and patient privacy.</span></p></td></tr></table></div></div><p class="paragraph" style="text-align:left;"></p><div class="section" style="background-color:#f8f8f8;border-color:#222222;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><div style="padding:14px 15px 14px;"><table class="bh__table" width="100%" style="border-collapse:collapse;"><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(3, 153, 205);font-family:Aptos Narrow, sans-serif;font-size:18pt;"><b>Community Voices</b></span></p></td></tr></table></div><div class="embed"><a class="embed__url" href="https://www.linkedin.com/pulse/adventures-rosie-shared-care-record-mark-hindle-chlbe/?trackingId=O44xVJHAQH62FyijFYQj3w%3D%3D&utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank"><div class="embed__content"><p class="embed__title"> The adventures of Rosie and the shared care record </p><p class="embed__description"> It was a privilege to be able to share my perspective on the implementation of longitudinal health records in the NHS at the UNGA Digital Health Symposium in New York today. I told the story of Rosie, my niece, an incredible young person who is affected by the inability of the NHS to share data and </p></div></a></div></div><p class="paragraph" style="text-align:left;"></p><div class="section" style="background-color:#f8f8f8;border-color:#222222;border-radius:5px;border-style:solid;border-width:0.5px;margin:5.0px 5.0px 5.0px 5.0px;padding:5.0px 5.0px 5.0px 5.0px;"><div style="padding:14px 15px 14px;"><table class="bh__table" width="100%" style="border-collapse:collapse;"><tr class="bh__table_row"><td class="bh__table_cell" width="100%"><p class="paragraph" style="text-align:center;"><span style="color:rgb(3, 153, 205);font-family:Aptos Narrow, sans-serif;font-size:18pt;"><b>Have Your Say</b></span></p></td></tr></table></div></div><div class="image"><img alt="" class="image__image" style="border-radius:0px 0px 0px 0px;border-style:solid;border-width:0px 0px 0px 0px;box-sizing:border-box;border-color:#E5E7EB;" src="https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/9b6578ae-a61b-40f5-998f-8b9a29feccf5/Icon_Blue.png?t=1726247509"/></div><p class="paragraph" style="text-align:center;"><span style="font-size:0.6rem;">Health Spotlight’s Sjogren’s Syndrome is a </span><span style="font-size:0.6rem;"><a class="link" href="https://www.contentive.com/?utm_source=sjogrens.healthspotlight.io&utm_medium=Weekly_Newsletter&utm_campaign=Heme_NIAB_Campaign" target="_blank" rel="noopener noreferrer nofollow">Contentive</a></span><span style="font-size:0.6rem;"> publication in the </span><span style="color:rgb(99, 32, 238);font-size:0.6rem;">Healthcare</span><span style="font-size:0.6rem;"> division</span></p></div><div class='beehiiv__footer'><br class='beehiiv__footer__break'><hr class='beehiiv__footer__line'><a target="_blank" class="beehiiv__footer_link" style="text-align: center;" href="https://www.beehiiv.com/?utm_campaign=f019323c-1fa0-46b9-a2c7-fe2dddc74d41&utm_medium=post_rss&utm_source=sjogren_s_syndrome_insights">Powered by beehiiv</a></div></div>
  ]]></content:encoded>
</item>

  </channel>
</rss>
